[10-Q] Markel Group Inc. Quarterly Earnings Report
Filing Impact
Filing Sentiment
Form Type
10-Q
Celularity Inc. filed an 8-K reporting a private placement executed on 14 Jul 2025 with one institutional investor. The company will sell 1,230,769 Class A shares plus matching two-year warrants at a combined price of $1.625 per unit, generating $2.0 million in gross proceeds. Warrants are immediately exercisable at $1.50 and, if fully exercised, could add 鈮�$1.85 million more.
Securities are being issued under a Section 4(a)(2)/Rule 506(b) exemption and therefore are unregistered. Net proceeds are earmarked for working capital and general corporate purposes. The Purchase Agreement and Warrant include customary reps, warranties and closing conditions; full forms are attached as Exhibits 10.1 & 10.2.
The equity issuance implies an estimated 鈮�3-4 % dilution to the current share base, with incremental dilution possible upon warrant exercise. While the raise bolsters short-term liquidity, the relatively small size highlights Celularity鈥檚 ongoing reliance on external financing to advance its placental-derived cell therapy programs.
Celularity Inc. ha depositato un 8-K che riporta un collocamento privato eseguito il 14 luglio 2025 con un investitore istituzionale. La societ脿 vender脿 1.230.769 azioni di Classe A 辫颈霉 warrant abbinati della durata di due anni, al prezzo combinato di 1,625 $ per unit脿, generando 2,0 milioni di dollari di proventi lordi. I warrant sono esercitabili immediatamente a 1,50 $ e, se esercitati completamente, potrebbero aggiungere circa 1,85 milioni di dollari in 辫颈霉.
I titoli vengono emessi ai sensi dell鈥檈senzione Sezione 4(a)(2)/Regola 506(b) e quindi sono non registrati. I proventi netti sono destinati a capitale circolante e scopi aziendali generali. L鈥橝ccordo di Acquisto e il Warrant includono dichiarazioni, garanzie e condizioni di chiusura consuete; i moduli completi sono allegati come Esibizioni 10.1 e 10.2.
L鈥檈missione di azioni implica una diluizione stimata di circa 3-4% della base azionaria attuale, con possibile ulteriore diluizione in caso di esercizio dei warrant. Sebbene l鈥檃umento rafforzi la liquidit脿 a breve termine, la dimensione relativamente contenuta evidenzia la continua dipendenza di Celularity da finanziamenti esterni per avanzare nei suoi programmi di terapia cellulare derivata dalla placenta.
Celularity Inc. present贸 un 8-K reportando una colocaci贸n privada realizada el 14 de julio de 2025 con un inversor institucional. La compa帽铆a vender谩 1.230.769 acciones Clase A 尘谩蝉 warrants a dos a帽os correspondientes, a un precio combinado de $1.625 por unidad, generando $2.0 millones en ingresos brutos. Los warrants son ejercitables inmediatamente a $1.50 y, si se ejercitan en su totalidad, podr铆an agregar aproximadamente $1.85 millones adicionales.
Los valores se emiten bajo la exenci贸n Secci贸n 4(a)(2)/Regla 506(b) y por tanto son no registrados. Los ingresos netos est谩n destinados a capital de trabajo y prop贸sitos corporativos generales. El Acuerdo de Compra y el Warrant incluyen declaraciones, garant铆as y condiciones de cierre habituales; los formularios completos est谩n adjuntos como Anexos 10.1 y 10.2.
La emisi贸n de acciones implica una diluci贸n estimada de aproximadamente 3-4% sobre la base accionaria actual, con posible diluci贸n adicional si se ejercen los warrants. Aunque la recaudaci贸n refuerza la liquidez a corto plazo, el tama帽o relativamente peque帽o destaca la continua dependencia de Celularity de financiamiento externo para avanzar en sus programas de terapia celular derivada de la placenta.
Celularity Inc.電� 2025雲� 7鞗� 14鞚� 頃� 旮瓣磤 韴瀽鞛愳檧 觳搓舶頃� 靷 氚办爼鞐� 雽�頃� 8-K毳� 鞝滌稖頄堨姷雼堧嫟. 須岇偓電� 1,230,769欤� 韥措灅鞀� A 欤检嫕瓿� 2雲� 毵岅赴 鞗岆煱韸�毳� 雼皜 $1.625鞐� 韺偆歆�搿� 韺愲Г頃橃棳 齑� 200毵� 雼煬鞚� 齑濎垬鞚奠潉 彀届稖頃� 鞓堨爼鞛呺媹雼�. 鞗岆煱韸鸽姅 歃夓嫓 頄夓偓 臧�電ロ晿氅� 頄夓偓 臧�瓴╈潃 $1.50鞚搓碃, 鞝勲秬 頄夓偓 鞁� 鞎� 185毵� 雼煬臧� 於旉皜霅� 靾� 鞛堨姷雼堧嫟.
歃濌秾鞚赌 靹轨厴 4(a)(2)/攴滌箼 506(b) 氅挫牅 頃橃棎 氚滍枆霅橃柎 霌彪霅橃 鞎婌潃 歃濌秾鞛呺媹雼�. 靾滌垬鞚奠潃 鞖挫爠鞛愲掣 氚� 鞚茧皹 旮办梾 氇╈爜鞐� 靷毄霅� 鞓堨爼鞛呺媹雼�. 毵るГ瓿勳暯靹滌檧 鞗岆煱韸胳棎電� 韱奠儊鞝侅澑 歆勳垹, 氤挫 氚� 膦呹舶 臁瓣贝鞚� 韽暔霅橃柎 鞛堨溂氅�, 鞝勳泊 靹滌嫕鞚� 攵�搿� 10.1 氚� 10.2鞐� 觳秬霅橃柎 鞛堨姷雼堧嫟.
鞚措矆 欤检嫕 氚滍枆鞚� 順勳灛 欤检嫕 旮半皹鞐� 雽�頃� 鞎� 3-4%鞚� 頋劃 須臣毳� 鞓堨儊頃橂┌, 鞗岆煱韸� 頄夓偓 鞁� 於旉皜 頋劃 臧�電レ劚鞚� 鞛堨姷雼堧嫟. 鞚措矆 鞛愱笀 臁半嫭鞚� 雼赴 鞙犽彊靹膘潉 臧曧檾頃橃毵�, 牍勱祼鞝� 靻岅窚氇澕電� 鞝愳潃 Celularity臧� 韮滊皹 鞙犽灅 靹疙彫 旃橂 頂勲攴鸽灗鞚� 歆勴枆頃橁赴 鞙勴暣 鞕鸽秬 鞛愱笀鞐� 瓿勳啀 鞚橃〈頃橁碃 鞛堨潓鞚� 氤挫棳欷嶋媹雼�.
Celularity Inc. a d茅pos茅 un 8-K signalant un placement priv茅 r茅alis茅 le 14 juillet 2025 avec un investisseur institutionnel. La soci茅t茅 vendra 1 230 769 actions de Classe A ainsi que des bons de souscription assortis d'une dur茅e de deux ans, au prix combin茅 de 1,625 $ par unit茅, g茅n茅rant 2,0 millions de dollars de produit brut. Les bons de souscription sont imm茅diatement exer莽ables 脿 1,50 $ et, s'ils sont enti猫rement exerc茅s, pourraient ajouter environ 1,85 million de dollars 蝉耻辫辫濒茅尘别苍迟补颈谤别蝉.
Les titres sont 茅mis en vertu d'une exemption Section 4(a)(2)/R猫gle 506(b) et sont donc non enregistr茅s. Les produits nets sont destin茅s au fonds de roulement et aux besoins g茅n茅raux de l'entreprise. Le contrat d'achat et les bons comprennent des d茅clarations, garanties et conditions de cl么ture habituelles; les formulaires complets sont joints en annexes 10.1 et 10.2.
L'茅mission d'actions implique une dilution estim茅e d'environ 3-4 % de la base d'actions actuelle, avec une dilution suppl茅mentaire possible en cas d'exercice des bons. Bien que cette lev茅e de fonds renforce la liquidit茅 脿 court terme, sa taille relativement modeste souligne la d茅pendance continue de Celularity au financement externe pour faire avancer ses programmes de th茅rapie cellulaire d茅riv茅s du placenta.
Celularity Inc. hat eine 8-K-Meldung eingereicht, die eine am 14. Juli 2025 durchgef眉hrte Privatplatzierung mit einem institutionellen Investor berichtet. Das Unternehmen wird 1.230.769 Class A Aktien sowie dazu passende zweij盲hrige Warrants zu einem kombinierten Preis von 1,625 $ pro Einheit verkaufen und damit 2,0 Millionen $ Bruttoerl枚s erzielen. Die Warrants sind sofort aus眉bbar zu 1,50 $ und k枚nnten bei vollst盲ndiger Aus眉bung zus盲tzlich etwa 1,85 Millionen $ einbringen.
Die Wertpapiere werden unter einer Section 4(a)(2)/Regel 506(b) Befreiung ausgegeben und sind daher nicht registriert. Die Nettoerl枚se sind f眉r Umlaufverm枚gen und allgemeine Unternehmenszwecke vorgesehen. Der Kaufvertrag und die Warrants enthalten 眉bliche Zusicherungen, Garantien und Abschlussbedingungen; vollst盲ndige Formulare sind als Anlagen 10.1 und 10.2 beigef眉gt.
Die Aktienausgabe impliziert eine gesch盲tzte 鈮�3-4 % Verw盲sserung der aktuellen Aktienbasis, mit m枚glicher zus盲tzlicher Verw盲sserung durch Aus眉bung der Warrants. W盲hrend die Kapitalerh枚hung die kurzfristige Liquidit盲t st盲rkt, unterstreicht die relativ geringe Gr枚脽e die anhaltende Abh盲ngigkeit von Celularity von externer Finanzierung zur Weiterentwicklung seiner zelltherapeutischen Programme auf Plazentabasis.
Positive
- $2 million gross proceeds provide immediate liquidity for working capital.
- Warrants priced above the unit price ($1.50 vs. $1.625), limiting near-term downward pressure.
Negative
- Issuance of 1.23 M shares and equal warrants causes dilution of roughly 3-4 %, with more if warrants exercised.
- Small raise relative to probable cash burn indicates continued financing risk.
Insights
TL;DR: $2 M cash in at modest discount aids liquidity but adds dilution; impact neutral-slight positive.
The $2 M injection lengthens Celularity鈥檚 cash runway by only a few quarters yet comes at an acceptable 8-9 % discount to the warrant strike. Investors should note the two-year warrants could double share issuance at a marginal premium, capping upside. Because the raise is small relative to cash burn, it postpones but does not remove further capital-raising risk. Overall balance-sheet effect is beneficial but not transformative.
TL;DR: Transaction signals continuing funding need; limited but helpful liquidity for pipeline progress.
Celularity鈥檚 cell-therapy programs are capital intensive. Securing a single investor on standard terms suggests market confidence remains, yet the modest size affirms fundraising avenues may be constrained. With warrants struck below historical prices, future dilution is likely. From a strategic standpoint, proceeds should cover near-term R&D milestones, but additional raises are probable before pivotal trials. Impact is incremental rather than catalytic.
Celularity Inc. ha depositato un 8-K che riporta un collocamento privato eseguito il 14 luglio 2025 con un investitore istituzionale. La societ脿 vender脿 1.230.769 azioni di Classe A 辫颈霉 warrant abbinati della durata di due anni, al prezzo combinato di 1,625 $ per unit脿, generando 2,0 milioni di dollari di proventi lordi. I warrant sono esercitabili immediatamente a 1,50 $ e, se esercitati completamente, potrebbero aggiungere circa 1,85 milioni di dollari in 辫颈霉.
I titoli vengono emessi ai sensi dell鈥檈senzione Sezione 4(a)(2)/Regola 506(b) e quindi sono non registrati. I proventi netti sono destinati a capitale circolante e scopi aziendali generali. L鈥橝ccordo di Acquisto e il Warrant includono dichiarazioni, garanzie e condizioni di chiusura consuete; i moduli completi sono allegati come Esibizioni 10.1 e 10.2.
L鈥檈missione di azioni implica una diluizione stimata di circa 3-4% della base azionaria attuale, con possibile ulteriore diluizione in caso di esercizio dei warrant. Sebbene l鈥檃umento rafforzi la liquidit脿 a breve termine, la dimensione relativamente contenuta evidenzia la continua dipendenza di Celularity da finanziamenti esterni per avanzare nei suoi programmi di terapia cellulare derivata dalla placenta.
Celularity Inc. present贸 un 8-K reportando una colocaci贸n privada realizada el 14 de julio de 2025 con un inversor institucional. La compa帽铆a vender谩 1.230.769 acciones Clase A 尘谩蝉 warrants a dos a帽os correspondientes, a un precio combinado de $1.625 por unidad, generando $2.0 millones en ingresos brutos. Los warrants son ejercitables inmediatamente a $1.50 y, si se ejercitan en su totalidad, podr铆an agregar aproximadamente $1.85 millones adicionales.
Los valores se emiten bajo la exenci贸n Secci贸n 4(a)(2)/Regla 506(b) y por tanto son no registrados. Los ingresos netos est谩n destinados a capital de trabajo y prop贸sitos corporativos generales. El Acuerdo de Compra y el Warrant incluyen declaraciones, garant铆as y condiciones de cierre habituales; los formularios completos est谩n adjuntos como Anexos 10.1 y 10.2.
La emisi贸n de acciones implica una diluci贸n estimada de aproximadamente 3-4% sobre la base accionaria actual, con posible diluci贸n adicional si se ejercen los warrants. Aunque la recaudaci贸n refuerza la liquidez a corto plazo, el tama帽o relativamente peque帽o destaca la continua dependencia de Celularity de financiamiento externo para avanzar en sus programas de terapia celular derivada de la placenta.
Celularity Inc.電� 2025雲� 7鞗� 14鞚� 頃� 旮瓣磤 韴瀽鞛愳檧 觳搓舶頃� 靷 氚办爼鞐� 雽�頃� 8-K毳� 鞝滌稖頄堨姷雼堧嫟. 須岇偓電� 1,230,769欤� 韥措灅鞀� A 欤检嫕瓿� 2雲� 毵岅赴 鞗岆煱韸�毳� 雼皜 $1.625鞐� 韺偆歆�搿� 韺愲Г頃橃棳 齑� 200毵� 雼煬鞚� 齑濎垬鞚奠潉 彀届稖頃� 鞓堨爼鞛呺媹雼�. 鞗岆煱韸鸽姅 歃夓嫓 頄夓偓 臧�電ロ晿氅� 頄夓偓 臧�瓴╈潃 $1.50鞚搓碃, 鞝勲秬 頄夓偓 鞁� 鞎� 185毵� 雼煬臧� 於旉皜霅� 靾� 鞛堨姷雼堧嫟.
歃濌秾鞚赌 靹轨厴 4(a)(2)/攴滌箼 506(b) 氅挫牅 頃橃棎 氚滍枆霅橃柎 霌彪霅橃 鞎婌潃 歃濌秾鞛呺媹雼�. 靾滌垬鞚奠潃 鞖挫爠鞛愲掣 氚� 鞚茧皹 旮办梾 氇╈爜鞐� 靷毄霅� 鞓堨爼鞛呺媹雼�. 毵るГ瓿勳暯靹滌檧 鞗岆煱韸胳棎電� 韱奠儊鞝侅澑 歆勳垹, 氤挫 氚� 膦呹舶 臁瓣贝鞚� 韽暔霅橃柎 鞛堨溂氅�, 鞝勳泊 靹滌嫕鞚� 攵�搿� 10.1 氚� 10.2鞐� 觳秬霅橃柎 鞛堨姷雼堧嫟.
鞚措矆 欤检嫕 氚滍枆鞚� 順勳灛 欤检嫕 旮半皹鞐� 雽�頃� 鞎� 3-4%鞚� 頋劃 須臣毳� 鞓堨儊頃橂┌, 鞗岆煱韸� 頄夓偓 鞁� 於旉皜 頋劃 臧�電レ劚鞚� 鞛堨姷雼堧嫟. 鞚措矆 鞛愱笀 臁半嫭鞚� 雼赴 鞙犽彊靹膘潉 臧曧檾頃橃毵�, 牍勱祼鞝� 靻岅窚氇澕電� 鞝愳潃 Celularity臧� 韮滊皹 鞙犽灅 靹疙彫 旃橂 頂勲攴鸽灗鞚� 歆勴枆頃橁赴 鞙勴暣 鞕鸽秬 鞛愱笀鞐� 瓿勳啀 鞚橃〈頃橁碃 鞛堨潓鞚� 氤挫棳欷嶋媹雼�.
Celularity Inc. a d茅pos茅 un 8-K signalant un placement priv茅 r茅alis茅 le 14 juillet 2025 avec un investisseur institutionnel. La soci茅t茅 vendra 1 230 769 actions de Classe A ainsi que des bons de souscription assortis d'une dur茅e de deux ans, au prix combin茅 de 1,625 $ par unit茅, g茅n茅rant 2,0 millions de dollars de produit brut. Les bons de souscription sont imm茅diatement exer莽ables 脿 1,50 $ et, s'ils sont enti猫rement exerc茅s, pourraient ajouter environ 1,85 million de dollars 蝉耻辫辫濒茅尘别苍迟补颈谤别蝉.
Les titres sont 茅mis en vertu d'une exemption Section 4(a)(2)/R猫gle 506(b) et sont donc non enregistr茅s. Les produits nets sont destin茅s au fonds de roulement et aux besoins g茅n茅raux de l'entreprise. Le contrat d'achat et les bons comprennent des d茅clarations, garanties et conditions de cl么ture habituelles; les formulaires complets sont joints en annexes 10.1 et 10.2.
L'茅mission d'actions implique une dilution estim茅e d'environ 3-4 % de la base d'actions actuelle, avec une dilution suppl茅mentaire possible en cas d'exercice des bons. Bien que cette lev茅e de fonds renforce la liquidit茅 脿 court terme, sa taille relativement modeste souligne la d茅pendance continue de Celularity au financement externe pour faire avancer ses programmes de th茅rapie cellulaire d茅riv茅s du placenta.
Celularity Inc. hat eine 8-K-Meldung eingereicht, die eine am 14. Juli 2025 durchgef眉hrte Privatplatzierung mit einem institutionellen Investor berichtet. Das Unternehmen wird 1.230.769 Class A Aktien sowie dazu passende zweij盲hrige Warrants zu einem kombinierten Preis von 1,625 $ pro Einheit verkaufen und damit 2,0 Millionen $ Bruttoerl枚s erzielen. Die Warrants sind sofort aus眉bbar zu 1,50 $ und k枚nnten bei vollst盲ndiger Aus眉bung zus盲tzlich etwa 1,85 Millionen $ einbringen.
Die Wertpapiere werden unter einer Section 4(a)(2)/Regel 506(b) Befreiung ausgegeben und sind daher nicht registriert. Die Nettoerl枚se sind f眉r Umlaufverm枚gen und allgemeine Unternehmenszwecke vorgesehen. Der Kaufvertrag und die Warrants enthalten 眉bliche Zusicherungen, Garantien und Abschlussbedingungen; vollst盲ndige Formulare sind als Anlagen 10.1 und 10.2 beigef眉gt.
Die Aktienausgabe impliziert eine gesch盲tzte 鈮�3-4 % Verw盲sserung der aktuellen Aktienbasis, mit m枚glicher zus盲tzlicher Verw盲sserung durch Aus眉bung der Warrants. W盲hrend die Kapitalerh枚hung die kurzfristige Liquidit盲t st盲rkt, unterstreicht die relativ geringe Gr枚脽e die anhaltende Abh盲ngigkeit von Celularity von externer Finanzierung zur Weiterentwicklung seiner zelltherapeutischen Programme auf Plazentabasis.
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________________
FORM 10-Q
______________________________________________________________________________________
or
Commission File Number: 001-15811
_________________________________________
(Exact name of registrant as specified in its charter)
___________________________________________________________________________________
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
(Address of principal executive offices) (Zip Code)
(804 ) 747-0136
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
| x | Accelerated filer | ☐ | Non-accelerated filer | ☐ | |||||||||||||
| Smaller reporting company | Emerging growth company | ||||||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x
Number of shares of the registrant's common stock outstanding at July 23, 2025: 12,652,001
Table of Contents
Markel Group Inc.
Form 10-Q
Index
| Page Number | ||||||||
PART I. FINANCIAL INFORMATION | ||||||||
| Item 1. | Financial Statements | |||||||
Consolidated Balance Sheets—June 30, 2025 and December 31, 2024 | 3 | |||||||
Consolidated Statements of Income and Comprehensive Income—Quarters and Six Months Ended June 30, 2025 and 2024 | 4 | |||||||
Consolidated Statements of Changes in Equity—Quarters and Six Months Ended June 30, 2025 and 2024 | 5 | |||||||
Condensed Consolidated Statements of Cash Flows—Six Months Ended June 30, 2025 and 2024 | 7 | |||||||
Notes to Consolidated Financial Statements | 8 | |||||||
| Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 24 | ||||||
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 45 | ||||||
| Item 4. | Controls and Procedures | 45 | ||||||
PART II. OTHER INFORMATION | ||||||||
Item 1A. | Risk Factors | 46 | ||||||
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 46 | ||||||
| Item 5. | Other Information | 46 | ||||||
| Item 6. | Exhibits | 47 | ||||||
Signatures | 49 | |||||||
2
Table of Contents
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
MARKEL GROUP INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
| June 30, 2025 | December 31, 2024 | ||||||||||
| (dollars in thousands) | (unaudited) | ||||||||||
| ASSETS | |||||||||||
| Investments, at estimated fair value: | |||||||||||
Fixed maturity securities, available-for-sale (amortized cost of $ | $ | $ | |||||||||
Equity securities (cost of $ | |||||||||||
| Short-term investments, available-for-sale (estimated fair value approximates cost) | |||||||||||
| Total Investments | |||||||||||
| Cash and cash equivalents | |||||||||||
| Restricted cash and cash equivalents | |||||||||||
| Receivables | |||||||||||
| Reinsurance recoverables | |||||||||||
| Deferred policy acquisition costs | |||||||||||
| Prepaid reinsurance premiums | |||||||||||
| Goodwill | |||||||||||
| Intangible assets | |||||||||||
| Other assets | |||||||||||
| Total Assets | $ | $ | |||||||||
| LIABILITIES AND EQUITY | |||||||||||
| Unpaid losses and loss adjustment expenses | $ | $ | |||||||||
| Life and annuity benefits | |||||||||||
| Unearned premiums | |||||||||||
| Payables to insurance and reinsurance companies | |||||||||||
Senior long-term debt and other debt (estimated fair value of $ | |||||||||||
| Other liabilities | |||||||||||
| Total Liabilities | |||||||||||
| Redeemable noncontrolling interests | |||||||||||
| Commitments and contingencies | |||||||||||
| Shareholders' equity: | |||||||||||
| Preferred stock | |||||||||||
| Common stock | |||||||||||
| Retained earnings | |||||||||||
| Accumulated other comprehensive loss | ( | ( | |||||||||
| Total Shareholders' Equity | |||||||||||
| Noncontrolling interests | |||||||||||
| Total Equity | |||||||||||
| Total Liabilities and Equity | $ | $ | |||||||||
See accompanying notes to consolidated financial statements.
3
Table of Contents
MARKEL GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
(Unaudited)
| Quarter Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (dollars in thousands, except per share data) | |||||||||||||||||||||||
| OPERATING REVENUES | |||||||||||||||||||||||
| Earned premiums | $ | $ | $ | $ | |||||||||||||||||||
| Net investment income | |||||||||||||||||||||||
| Net investment gains (losses) | ( | ||||||||||||||||||||||
| Products revenues | |||||||||||||||||||||||
| Services and other revenues | |||||||||||||||||||||||
| Total Operating Revenues | |||||||||||||||||||||||
| OPERATING EXPENSES | |||||||||||||||||||||||
| Losses and loss adjustment expenses | |||||||||||||||||||||||
| Underwriting, acquisition and insurance expenses | |||||||||||||||||||||||
| Products expenses | |||||||||||||||||||||||
| Services and other expenses | |||||||||||||||||||||||
| Amortization of acquired intangible assets | |||||||||||||||||||||||
| Total Operating Expenses | |||||||||||||||||||||||
| Operating Income | |||||||||||||||||||||||
| Interest expense | ( | ( | ( | ( | |||||||||||||||||||
| Foreign exchange gains (losses) | ( | ( | |||||||||||||||||||||
| Income Before Income Taxes | |||||||||||||||||||||||
| Income tax expense | ( | ( | ( | ( | |||||||||||||||||||
| Net Income | |||||||||||||||||||||||
| Net income attributable to noncontrolling interests | ( | ( | ( | ( | |||||||||||||||||||
| Net Income to Shareholders | |||||||||||||||||||||||
Preferred stock dividends and redemption premiums | ( | ( | ( | ( | |||||||||||||||||||
| Net Income to Common Shareholders | $ | $ | $ | $ | |||||||||||||||||||
| OTHER COMPREHENSIVE INCOME (LOSS) | |||||||||||||||||||||||
Change in net unrealized losses on available-for-sale investments, net of taxes: | |||||||||||||||||||||||
| Net holding gains (losses) arising during the period | $ | $ | ( | $ | $ | ( | |||||||||||||||||
| Reclassification adjustments for net losses in net income | |||||||||||||||||||||||
Change in net unrealized losses on available-for-sale investments, net of taxes | ( | ( | |||||||||||||||||||||
| Change in discount rate for life and annuity benefits, net of taxes | ( | ||||||||||||||||||||||
| Change in foreign currency translation adjustments, net of taxes | ( | ( | |||||||||||||||||||||
| Change in net actuarial pension loss, net of taxes | |||||||||||||||||||||||
| Total Other Comprehensive Income (Loss) | ( | ( | |||||||||||||||||||||
| Comprehensive Income | |||||||||||||||||||||||
| Comprehensive income attributable to noncontrolling interests | ( | ( | ( | ( | |||||||||||||||||||
| Comprehensive Income to Shareholders | $ | $ | $ | $ | |||||||||||||||||||
| NET INCOME PER COMMON SHARE | |||||||||||||||||||||||
| Basic | $ | $ | $ | $ | |||||||||||||||||||
| Diluted | $ | $ | $ | $ | |||||||||||||||||||
See accompanying notes to consolidated financial statements.
4
Table of Contents
MARKEL GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(Unaudited)
| Quarter Ended June 30, 2025 | Preferred Stock | Common Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interests | Total Equity | Redeemable Noncontrolling Interests | |||||||||||||||||||||||||||||||||||||||
| (dollars in thousands) | |||||||||||||||||||||||||||||||||||||||||||||||
| March 31, 2025 | $ | $ | $ | $ | ( | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||
| Net income | |||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | |||||||||||||||||||||||||||||||||||||||||||||||
| Comprehensive income | |||||||||||||||||||||||||||||||||||||||||||||||
| Repurchase of common stock | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Preferred stock dividends | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Redemption of preferred stock | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
Equity awards expensed | |||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment of redeemable noncontrolling interests | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Purchase of noncontrolling interests | ( | ||||||||||||||||||||||||||||||||||||||||||||||
| Other | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||
| June 30, 2025 | $ | $ | $ | $ | ( | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||
| Six Months Ended June 30, 2025 | Preferred Stock | Common Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interests | Total Equity | Redeemable Noncontrolling Interests | |||||||||||||||||||||||||||||||||||||||
| (dollars in thousands) | |||||||||||||||||||||||||||||||||||||||||||||||
| December 31, 2024 | $ | $ | $ | $ | ( | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||
| Net income | |||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | |||||||||||||||||||||||||||||||||||||||||||||||
| Comprehensive income | |||||||||||||||||||||||||||||||||||||||||||||||
| Repurchase of common stock | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Preferred stock dividends | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Redemption of preferred stock | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
Equity awards expensed | |||||||||||||||||||||||||||||||||||||||||||||||
| Acquisition of EPI | |||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment of redeemable noncontrolling interests | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
| Purchase of noncontrolling interests | ( | ||||||||||||||||||||||||||||||||||||||||||||||
| Other | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||
| June 30, 2025 | $ | $ | $ | $ | ( | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||
See accompanying notes to consolidated financial statements.
5
Table of Contents
MARKEL GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(Unaudited)
| Quarter Ended June 30, 2024 | Preferred Stock | Common Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interests | Total Equity | Redeemable Noncontrolling Interests | |||||||||||||||||||||||||||||||||||||||
| (dollars in thousands) | |||||||||||||||||||||||||||||||||||||||||||||||
| March 31, 2024 | $ | $ | $ | $ | ( | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||
| Net income | |||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Comprehensive income | |||||||||||||||||||||||||||||||||||||||||||||||
| Repurchase of common stock | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Preferred stock dividends | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Equity awards expensed | |||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment of redeemable noncontrolling interests | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Purchase of noncontrolling interest | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
| Other | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
| June 30, 2024 | $ | $ | $ | $ | ( | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||
| Six Months Ended June 30, 2024 | Preferred Stock | Common Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interests | Total Equity | Redeemable Noncontrolling Interests | |||||||||||||||||||||||||||||||||||||||
| (dollars in thousands) | |||||||||||||||||||||||||||||||||||||||||||||||
| December 31, 2023 | $ | $ | $ | $ | ( | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||
| Net income | |||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Comprehensive income | |||||||||||||||||||||||||||||||||||||||||||||||
| Repurchase of common stock | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Preferred stock dividends | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Equity awards expensed | |||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment of redeemable noncontrolling interests | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Purchase of noncontrolling interest | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
| Other | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
| June 30, 2024 | $ | $ | $ | $ | ( | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||
See accompanying notes to consolidated financial statements.
6
Table of Contents
MARKEL GROUP INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
| Six Months Ended June 30, | |||||||||||
| 2025 | 2024 | ||||||||||
(dollars in thousands) | |||||||||||
| OPERATING ACTIVITIES | |||||||||||
| Net income | $ | $ | |||||||||
| Adjustments to reconcile net income to net cash provided by operating activities | ( | ||||||||||
| Net Cash Provided By Operating Activities | |||||||||||
| INVESTING ACTIVITIES | |||||||||||
| Proceeds from sales, maturities, calls and prepayments of fixed maturity securities | |||||||||||
| Cost of fixed maturity securities purchased | ( | ( | |||||||||
| Proceeds from sales of equity securities | |||||||||||
| Cost of equity securities purchased | ( | ( | |||||||||
| Net change in short-term investments | ( | ||||||||||
| Additions to property and equipment | ( | ( | |||||||||
| Acquisitions, net of cash acquired | ( | ( | |||||||||
| Other | ( | ||||||||||
| Net Cash Provided (Used) By Investing Activities | ( | ||||||||||
| FINANCING ACTIVITIES | |||||||||||
| Additions to senior long-term debt and other debt | |||||||||||
| Repayment of senior long-term debt and other debt | ( | ( | |||||||||
| Repurchases of common stock | ( | ( | |||||||||
| Dividends paid on preferred stock | ( | ( | |||||||||
Redemption of preferred stock | ( | ||||||||||
| Purchase of noncontrolling interests | ( | ( | |||||||||
| Other | ( | ( | |||||||||
| Net Cash Provided (Used) By Financing Activities | ( | ||||||||||
| Effect of foreign currency rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents | ( | ||||||||||
| Increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents | ( | ||||||||||
| Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period | |||||||||||
| CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS AT END OF PERIOD | $ | $ | |||||||||
See accompanying notes to consolidated financial statements.
7
Table of Contents
MARKEL GROUP INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. Summary of Significant Accounting Policies
Markel Group Inc. (Markel Group) is a holding company comprised of a diverse group of companies and investments with specialty insurance at its core. Through its wholly owned subsidiary, Markel Ventures, Inc. (Markel Ventures), Markel Group owns controlling interests in businesses that operate in a variety of industries. See note 2 for details regarding reportable segments.
a) Basis of Presentation. The consolidated balance sheet as of June 30, 2025 and the related consolidated statements of income and comprehensive income and changes in equity for the quarters and six months ended June 30, 2025 and 2024, and the condensed consolidated statements of cash flows for the six months ended June 30, 2025 and 2024 are unaudited. In the opinion of management, all adjustments necessary for fair presentation of such consolidated financial statements have been included. Such adjustments consist only of normal, recurring items. Interim results are not necessarily indicative of results of operations for the entire year. The consolidated balance sheet as of December 31, 2024 was derived from Markel Group's audited annual consolidated financial statements.
The accompanying consolidated financial statements have been prepared in accordance with United States (U.S.) generally accepted accounting principles (GAAP) and include the accounts of Markel Group and its consolidated subsidiaries, as well as variable interest entities (VIEs) that meet the requirements for consolidation (the Company). All significant intercompany balances and transactions have been eliminated in consolidation. The Company consolidates the results of its Markel Ventures subsidiaries on a one-month lag, with the exception of significant transactions or events that occur during the intervening period. Certain prior period amounts have been reclassified to conform to the current period presentation.
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities. Actual results may differ materially from the estimates and assumptions used in preparing the consolidated financial statements.
The consolidated financial statements and notes are presented as permitted by Form 10-Q and do not contain certain information included in the Company's annual consolidated financial statements and notes. For a more complete description of the Company's business and accounting policies, readers are urged to review the Company's 2024 Annual Report on Form 10‑K.
b) Recent Accounting Pronouncements
Accounting Standards Not Yet Adopted
In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The standard requires public companies, on an annual basis, to provide enhanced rate reconciliation disclosures, including disclosure of specific categories and additional information for reconciling items that meet a quantitative threshold. The standard also requires public companies to, among other things, disaggregate income taxes paid by federal, state and foreign taxes. ASU No. 2023-09 becomes effective for the Company's 2025 Annual Report on Form 10-K. The standard only impacts required disclosures and will not impact the Company's financial position, results of operations or cash flows. The Company is currently evaluating the impact of ASU No. 2023-09 on its disclosures.
In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures. The standard requires disclosure of certain prescribed costs and expenses within the notes to consolidated financial statements. ASU No. 2024-03 becomes effective for the Company's 2027 Annual Report on Form 10-K. The standard only impacts required disclosures and will not impact the Company's financial position, results of operations or cash flows. The Company is currently in the early stages of evaluating the impact of ASU No. 2024-23 on its disclosures.
8
Table of Contents
2. Segment Reporting Disclosures
The Company has three reportable segments: Markel Insurance, Investing and Markel Ventures.
The Markel Insurance segment is the Company's core specialty insurance business, which is comprised of underwriting operations, as well as certain other insurance-related operations and strategic investments that complement and support its underwriting operations.
In the first half of 2025, management made changes to the structure and leadership of its insurance operations, which resulted in changes to its reportable segments. The newly created Markel Insurance segment aligns with the business and its network of insurance subsidiaries under the common leadership of its chief executive officer, with underwriting operations that previously were reported through the Company's Insurance and Reinsurance segments. Other insurance activities attributed to the Markel Insurance subsidiaries, including the run-off of certain discontinued lines of business, were previously reported outside of our reportable segments within the Company's other insurance operations. The State National automobile collateral protection product line, which is part of our State National business, was previously included in the Insurance segment and is now included with the rest of the State National business. Prior periods have been recast to conform to the current presentation.
Following the re-segmentation of the Company's insurance operations, the Company's other insurance operations primarily consist of the results of the Company's State National and Nephila businesses. For purposes of segment reporting, none of these other insurance operations are considered to be reportable segments.
The Company's Investing segment includes investing activities related to invested assets within the Company's insurance operations, as well as investing activities at Markel Group. Invested assets managed through the Investing segment include the Company's portfolio of publicly traded fixed maturity and equity securities, as well as cash and short-term investments.
The Markel Ventures segment primarily consists of controlling interests in a diverse portfolio of businesses that operate in various industries. The Company's chief operating decision maker reviews and assesses Markel Ventures' performance in the aggregate, as a single operating segment.
Management continues to evaluate the Company's segments as its strategy evolves and may further refine its segments.
Segment profit for all of the Company's segments is measured by operating income. Segment operating income excludes amortization of intangible assets, which arises from purchase accounting for acquisitions. The chief operating decision maker does not consider amortization of acquired intangible assets in assessing the financial performance of, or allocating resources to, operating segments. Amortization of acquired intangible assets is considered a corporate expense because it is not a cost of operating the underlying businesses.
9
Table of Contents
a) The following tables summarize the Company's segment disclosures.
| Quarter Ended June 30, 2025 | |||||||||||||||||||||||||||||||||||
| (dollars in thousands) | Markel Insurance | Investing | Markel Ventures | Other insurance operations | Corporate | Consolidated | |||||||||||||||||||||||||||||
| Earned premiums | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| Net investment income | |||||||||||||||||||||||||||||||||||
| Net investment gains | |||||||||||||||||||||||||||||||||||
| Products revenues | |||||||||||||||||||||||||||||||||||
| Services and other revenues | |||||||||||||||||||||||||||||||||||
| Total operating revenues | |||||||||||||||||||||||||||||||||||
| Losses and loss adjustment expenses: | |||||||||||||||||||||||||||||||||||
Current accident year - attritional | ( | ( | ( | ||||||||||||||||||||||||||||||||
Current accident year - catastrophe | |||||||||||||||||||||||||||||||||||
| Prior accident years | ( | ||||||||||||||||||||||||||||||||||
| Underwriting, acquisition and insurance expenses: | |||||||||||||||||||||||||||||||||||
| Amortization of policy acquisition costs | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Other underwriting expenses | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Products expenses | ( | ( | |||||||||||||||||||||||||||||||||
| Services and other expenses | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Amortization of acquired intangible assets | ( | ( | |||||||||||||||||||||||||||||||||
| Operating income | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||
| Interest expense | ( | ||||||||||||||||||||||||||||||||||
| Net foreign exchange losses | ( | ||||||||||||||||||||||||||||||||||
| Income before income taxes | $ | ||||||||||||||||||||||||||||||||||
| Quarter Ended June 30, 2024 | |||||||||||||||||||||||||||||||||||
| (dollars in thousands) | Markel Insurance | Investing | Markel Ventures | Other insurance operations | Corporate | Consolidated | |||||||||||||||||||||||||||||
| Earned premiums | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| Net investment income | |||||||||||||||||||||||||||||||||||
| Net investment losses | ( | ( | |||||||||||||||||||||||||||||||||
| Products revenues | |||||||||||||||||||||||||||||||||||
| Services and other revenues | |||||||||||||||||||||||||||||||||||
| Total operating revenues | |||||||||||||||||||||||||||||||||||
| Losses and loss adjustment expenses: | |||||||||||||||||||||||||||||||||||
Current accident year - attritional | ( | ( | ( | ||||||||||||||||||||||||||||||||
Current accident year - catastrophe | |||||||||||||||||||||||||||||||||||
| Prior accident years | ( | ||||||||||||||||||||||||||||||||||
| Underwriting, acquisition and insurance expenses: | |||||||||||||||||||||||||||||||||||
| Amortization of policy acquisition costs | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Other underwriting expenses | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Products expenses | ( | ( | |||||||||||||||||||||||||||||||||
| Services and other expenses | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Amortization of acquired intangible assets | ( | ( | |||||||||||||||||||||||||||||||||
| Operating income | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||
| Interest expense | ( | ||||||||||||||||||||||||||||||||||
| Net foreign exchange gains | |||||||||||||||||||||||||||||||||||
| Income before income taxes | $ | ||||||||||||||||||||||||||||||||||
10
Table of Contents
| Six Months Ended June 30, 2025 | |||||||||||||||||||||||||||||||||||
| (dollars in thousands) | Markel Insurance | Investing | Markel Ventures | Other insurance operations | Corporate | Consolidated | |||||||||||||||||||||||||||||
| Earned premiums | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| Net investment income | |||||||||||||||||||||||||||||||||||
| Net investment gains | |||||||||||||||||||||||||||||||||||
| Products revenues | |||||||||||||||||||||||||||||||||||
| Services and other revenues | |||||||||||||||||||||||||||||||||||
| Total operating revenues | |||||||||||||||||||||||||||||||||||
| Losses and loss adjustment expenses: | |||||||||||||||||||||||||||||||||||
Current accident year - attritional | ( | ( | ( | ||||||||||||||||||||||||||||||||
Current accident year - catastrophe | ( | ( | |||||||||||||||||||||||||||||||||
| Prior accident years | |||||||||||||||||||||||||||||||||||
| Underwriting, acquisition and insurance expenses: | |||||||||||||||||||||||||||||||||||
| Amortization of policy acquisition costs | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Other underwriting expenses | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Products expenses | ( | ( | |||||||||||||||||||||||||||||||||
| Services and other expenses | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Amortization of acquired intangible assets | ( | ( | |||||||||||||||||||||||||||||||||
| Operating income | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||
| Interest expense | ( | ||||||||||||||||||||||||||||||||||
| Net foreign exchange losses | ( | ||||||||||||||||||||||||||||||||||
| Income before income taxes | $ | ||||||||||||||||||||||||||||||||||
| Six Months Ended June 30, 2024 | |||||||||||||||||||||||||||||||||||
| (dollars in thousands) | Markel Insurance | Investing | Markel Ventures | Other insurance operations | Corporate | Consolidated | |||||||||||||||||||||||||||||
| Earned premiums | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| Net investment income | |||||||||||||||||||||||||||||||||||
| Net investment gains | |||||||||||||||||||||||||||||||||||
| Products revenues | |||||||||||||||||||||||||||||||||||
| Services and other revenues | |||||||||||||||||||||||||||||||||||
| Total operating revenues | |||||||||||||||||||||||||||||||||||
| Losses and loss adjustment expenses: | |||||||||||||||||||||||||||||||||||
Current accident year - attritional | ( | ( | ( | ||||||||||||||||||||||||||||||||
Current accident year - catastrophe | |||||||||||||||||||||||||||||||||||
| Prior accident years | ( | ||||||||||||||||||||||||||||||||||
| Underwriting, acquisition and insurance expenses: | |||||||||||||||||||||||||||||||||||
| Amortization of policy acquisition costs | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Other underwriting expenses | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Products expenses | ( | ( | |||||||||||||||||||||||||||||||||
| Services and other expenses | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Amortization of acquired intangible assets | ( | ( | |||||||||||||||||||||||||||||||||
| Operating income | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||
| Interest expense | ( | ||||||||||||||||||||||||||||||||||
| Net foreign exchange gains | |||||||||||||||||||||||||||||||||||
| Income before income taxes | $ | ||||||||||||||||||||||||||||||||||
11
Table of Contents
b) The following amounts attributable to the Markel Ventures segment are also reviewed, or included in measures reviewed, by the Company's chief operating decision maker.
| Quarter Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (dollars in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Depreciation expense | $ | $ | $ | $ | |||||||||||||||||||
| Capital expenditures | $ | $ | $ | $ | |||||||||||||||||||
c) The following table reconciles segment assets to the Company's consolidated balance sheets.
| (dollars in thousands) | June 30, 2025 | December 31, 2024 | |||||||||
| Segment assets: | |||||||||||
| Investing | $ | $ | |||||||||
Markel Insurance | |||||||||||
| Markel Ventures | |||||||||||
| Total segment assets | |||||||||||
Other insurance operations | |||||||||||
| Total assets | $ | $ | |||||||||
d) As a result of the segment changes within its insurance operations in the second quarter of 2025, the Company reassessed its reporting units and reallocated goodwill by reporting unit within its insurance operations. As of June 30, 2025, goodwill attributable to the Company's Markel Insurance segment and its other insurance operations was $1.0 billion and $490.3 million, respectively. Immediately prior to the change in reporting units within its insurance operations, the Company tested goodwill for impairment and determined that there was no
3. Acquisitions
Educational Partners International
In September 2024, the Company acquired a 68 % ownership interest in Educational Partners International (EPI), a company that sponsors international teachers for placements in schools in the U.S. Total consideration for the Company's investment was $167.7 million, all of which was cash. The Company has the option to acquire the remaining equity interests and the remaining equity holders have the option to sell their interests to the Company in the future. Through January 15, 2025, the Company's investment was accounted for under the equity method, as the Company did not have control over the business due to regulatory approval that was still pending. On January 16, 2025, the Company received regulatory approval, which resulted in the control and consolidation of EPI. The fair value of the investment on the consolidation date was preliminarily allocated to the acquired assets and liabilities of EPI based on estimated fair value at the consolidation date. The Company recognized goodwill of $70.3 million, intangible assets of $177.0 million and redeemable noncontrolling interest of $81.2 million. Goodwill is primarily attributable to expected future earnings and cash flow potential of EPI, and it is expected to be deductible for income tax purposes. The primary intangible asset acquired is an indefinite-lived intangible asset for a designation from the U.S. Department of State that authorizes EPI to sponsor international teachers for placements in schools in the U.S. Results attributable to EPI are included in the Company's Markel Ventures segment.
The Company has not completed the process of determining the fair value of the assets acquired and liabilities assumed. As a result, the fair value recorded for these items is a provisional estimate and is subject to adjustment. Once completed, any adjustments resulting from the valuations may impact the individual amounts recorded for assets acquired and liabilities assumed, as well as the residual goodwill.
Valor Environmental
In June 2024, the Company acquired 98 % of Valor Environmental (Valor), an environmental services company providing erosion control and related services to commercial development sites and homebuilders throughout the U.S. The Company has the option to acquire the remaining equity interests and the remaining equity holders have the option to sell their interests to the Company in the future. Total consideration for the transaction was $156.4
12
Table of Contents
As of June 30, 2024, the purchase price was preliminarily allocated to the acquired assets and liabilities of Valor based on estimated fair value at the acquisition date. In the first quarter of 2025, the Company completed the process of determining the fair value of the assets acquired and liabilities assumed with Valor and recognized goodwill of $73.4 million and intangible assets of $92.5 million. The final purchase price allocation reflected differences from the preliminary purchase price allocation, including a $43.5 million increase in the amount recognized for intangible assets upon completion of a third-party valuation and an increase in the corresponding deferred tax liability. The final purchase price allocation adjustments resulted in a $34.2 million net decrease to goodwill from the preliminary amount recognized. Goodwill is primarily attributable to expected future earnings and cash flow potential of Valor, and a portion of it is not deductible for income tax purposes. Intangible assets include $82.0 million of customer relationships, $6.0 million of trade names and $4.5 million of other intangible assets, which are being amortized over 17 years, 15 years and 5 years, respectively. Results attributable to Valor are included in the Company's Markel Ventures segment.
4. Investments
a) The following tables summarize the Company's available-for-sale investments. Agency mortgage-backed securities include securities issued by U.S. government-sponsored enterprises and U.S. government agencies. The net unrealized holding gains (losses) in the tables below are presented before taxes.
| June 30, 2025 | |||||||||||||||||||||||||||||
| (dollars in thousands) | Amortized Cost | Gross Unrealized Holding Gains | Gross Unrealized Holding Losses | Estimated Fair Value | |||||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||||||||
| U.S. Treasury securities | $ | $ | $ | ( | $ | ||||||||||||||||||||||||
| U.S. government-sponsored enterprises | ( | ||||||||||||||||||||||||||||
| Obligations of states, municipalities and political subdivisions | ( | ||||||||||||||||||||||||||||
Foreign governments, agencies and supranationals | ( | ||||||||||||||||||||||||||||
Agency mortgage-backed securities | ( | ||||||||||||||||||||||||||||
Non-agency mortgage-backed securities | ( | ||||||||||||||||||||||||||||
Corporate and university bonds | ( | ||||||||||||||||||||||||||||
| Total fixed maturity securities | ( | ||||||||||||||||||||||||||||
| Short-term investments | ( | ||||||||||||||||||||||||||||
| Investments, available-for-sale | $ | $ | $ | ( | $ | ||||||||||||||||||||||||
| December 31, 2024 | |||||||||||||||||||||||
| (dollars in thousands) | Amortized Cost | Gross Unrealized Holding Gains | Gross Unrealized Holding Losses | Estimated Fair Value | |||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||
| U.S. Treasury securities | $ | $ | $ | ( | $ | ||||||||||||||||||
| U.S. government-sponsored enterprises | ( | ||||||||||||||||||||||
| Obligations of states, municipalities and political subdivisions | ( | ||||||||||||||||||||||
Foreign governments, agencies and supranationals | ( | ||||||||||||||||||||||
Agency mortgage-backed securities | ( | ||||||||||||||||||||||
Non-agency mortgage-backed securities | ( | ||||||||||||||||||||||
Corporate and university bonds | ( | ||||||||||||||||||||||
| Total fixed maturity securities | ( | ||||||||||||||||||||||
| Short-term investments | ( | ||||||||||||||||||||||
| Investments, available-for-sale | $ | $ | $ | ( | $ | ||||||||||||||||||
13
Table of Contents
b) The following tables summarize gross unrealized investment losses on available-for-sale investments by the length of time that securities have continuously been in an unrealized loss position.
| June 30, 2025 | |||||||||||||||||||||||||||||||||||
| Less than 12 months | 12 months or longer | Total | |||||||||||||||||||||||||||||||||
| (dollars in thousands) | Estimated Fair Value | Gross Unrealized Holding Losses | Estimated Fair Value | Gross Unrealized Holding Losses | Estimated Fair Value | Gross Unrealized Holding Losses | |||||||||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||||||||||||||
| U.S. Treasury securities | $ | $ | ( | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||
| U.S. government-sponsored enterprises | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Obligations of states, municipalities and political subdivisions | ( | ( | ( | ||||||||||||||||||||||||||||||||
Foreign governments, agencies and supranationals | ( | ( | ( | ||||||||||||||||||||||||||||||||
Agency mortgage-backed securities | ( | ( | ( | ||||||||||||||||||||||||||||||||
Non-agency mortgage-backed securities | ( | ( | |||||||||||||||||||||||||||||||||
Corporate and university bonds | ( | ( | |||||||||||||||||||||||||||||||||
| Total fixed maturity securities | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Short-term investments | ( | ( | |||||||||||||||||||||||||||||||||
| Total | $ | $ | ( | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||
At June 30, 2025, the Company held 1,085 available-for-sale securities in an unrealized loss position with a total estimated fair value of $9.7 billion and gross unrealized losses of $406.3 million. Of these 1,085 securities, 885 securities had been in a continuous unrealized loss position for one year or longer and had a total estimated fair value of $6.9 billion and gross unrealized losses of $390.6 million.
| December 31, 2024 | |||||||||||||||||||||||||||||||||||
| Less than 12 months | 12 months or longer | Total | |||||||||||||||||||||||||||||||||
| (dollars in thousands) | Estimated Fair Value | Gross Unrealized Holding Losses | Estimated Fair Value | Gross Unrealized Holding Losses | Estimated Fair Value | Gross Unrealized Holding Losses | |||||||||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||||||||||||||
| U.S. Treasury securities | $ | $ | ( | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||
| U.S. government-sponsored enterprises | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Obligations of states, municipalities and political subdivisions | ( | ( | ( | ||||||||||||||||||||||||||||||||
Foreign governments, agencies and supranationals | ( | ( | ( | ||||||||||||||||||||||||||||||||
Agency mortgage-backed securities | ( | ( | ( | ||||||||||||||||||||||||||||||||
Non-agency mortgage-backed securities | ( | ( | |||||||||||||||||||||||||||||||||
Corporate and university bonds | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Total fixed maturity securities | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Short-term investments | ( | ( | |||||||||||||||||||||||||||||||||
| Total | $ | $ | ( | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||
14
Table of Contents
At December 31, 2024, the Company held 1,485 available-for-sale securities in an unrealized loss position with a total estimated fair value of $12.6 billion and gross unrealized losses of $743.0 million. Of these 1,485 securities, 966 securities had been in a continuous unrealized loss position for one year or longer and had a total estimated fair value of $7.4 billion and gross unrealized losses of $633.1 million.
The Company completes a detailed analysis each quarter to assess whether the decline in the fair value of any investment below its cost basis is the result of a credit loss. All available-for-sale securities with unrealized losses are reviewed. The Company considers many factors in completing its quarterly review of securities with unrealized losses for credit-related impairment to determine whether a credit loss exists, including the extent to which fair value is below cost, the implied yield to maturity, rating downgrades of the security and whether or not the issuer has failed to make scheduled principal or interest payments. The Company also takes into consideration information about the financial condition of the issuer and industry factors that could negatively impact the issuer.
If the decline in fair value of an available-for-sale security below its amortized cost is considered to be the result of a credit loss, the Company compares the estimated present value of the cash flows expected to be collected to the amortized cost of the security. The extent to which the estimated present value of the cash flows expected to be collected is less than the amortized cost of the security represents the credit loss, which is recorded as an allowance and recognized in net income. The allowance is limited to the difference between the fair value and the amortized cost of the security. Any remaining decline in fair value represents the non-credit portion of the impairment, which is recognized in other comprehensive income. The Company did not
Quarterly, the Company also considers whether it intends to sell an available-for-sale security or if it is more likely than not that it will be required to sell a security before recovery of its amortized cost. In these instances, a decline in fair value is recognized in net income based on the fair value of the security at the time of assessment, resulting in a new cost basis for the security.
c) The amortized cost and estimated fair value of fixed maturity securities at June 30, 2025 are shown below by contractual maturity.
| (dollars in thousands) | Amortized Cost | Estimated Fair Value | |||||||||
| Due in one year or less | $ | $ | |||||||||
| Due after one year through five years | |||||||||||
| Due after five years through ten years | |||||||||||
| Due after ten years | |||||||||||
Mortgage-backed securities | |||||||||||
| Total fixed maturity securities | $ | $ | |||||||||
d) The following table presents the components of net investment income.
| Quarter Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (dollars in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Interest: | |||||||||||||||||||||||
| Fixed maturity securities | $ | $ | $ | $ | |||||||||||||||||||
| Short-term investments | |||||||||||||||||||||||
Cash and cash equivalents and restricted cash and cash equivalents | |||||||||||||||||||||||
| Dividends on equity securities | |||||||||||||||||||||||
| Investment expenses | ( | ( | ( | ( | |||||||||||||||||||
Net investment income | $ | $ | $ | $ | |||||||||||||||||||
15
Table of Contents
e) The following table presents the components of net investment gains (losses) included in net income and the change in net unrealized losses included in other comprehensive income (loss). Gross realized investment gains and losses on fixed maturity securities, short-term investments and other investments were not material to the consolidated financial statements and are presented on a net basis in the following table.
| Quarter Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (dollars in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Fixed maturity securities, short-term investments and other investments: | |||||||||||||||||||||||
| Net realized investment losses | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| Equity securities: | |||||||||||||||||||||||
| Change in fair value of securities sold during the period | ( | ( | ( | ||||||||||||||||||||
| Change in fair value of securities held at the end of the period | ( | ||||||||||||||||||||||
| Total change in fair value | ( | ||||||||||||||||||||||
| Net investment gains (losses) | $ | $ | ( | $ | $ | ||||||||||||||||||
| Change in net unrealized losses on available-for-sale investments included in other comprehensive income (loss): | |||||||||||||||||||||||
| Fixed maturity securities | $ | $ | ( | $ | $ | ( | |||||||||||||||||
| Short-term investments | ( | ( | |||||||||||||||||||||
| Net increase (decrease) | $ | $ | ( | $ | $ | ( | |||||||||||||||||
5. Fair Value Measurements
FASB Accounting Standards Codification (ASC) 820, Fair Value Measurements and Disclosures, establishes a three-level hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure the assets or liabilities fall within different levels of the hierarchy, the classification is based on the lowest level input that is significant to the fair value measurement of the asset or liability.
Classification of assets and liabilities within the hierarchy considers the markets in which the assets and liabilities are traded and the reliability and transparency of the assumptions used to determine fair value. The hierarchy requires the use of observable market data when available. The levels of the hierarchy are defined as follows:
•Level 1 – Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities traded in active markets.
•Level 2 – Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability and market-corroborated inputs.
•Level 3 – Inputs to the valuation methodology are unobservable for the asset or liability and are significant to the fair value measurement.
In accordance with ASC 820, the Company determines fair value based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value, the Company uses various methods, including the market, income and cost approaches. The Company uses valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. The following section describes the valuation methodologies used by the Company to measure assets and liabilities at fair value, including an indication of the level within the fair value hierarchy in which each asset or liability is generally classified.
16
Table of Contents
Available-for-sale investments and equity securities. Available-for-sale investments and equity securities are recorded at fair value on a recurring basis. Available-for-sale investments include fixed maturity securities and short-term investments. Fair value is determined by the Company after considering various sources of information, including information provided by a third-party pricing service. The pricing service provides prices for substantially all of the Company's fixed maturity securities and equity securities. In determining fair value, the Company generally does not adjust the prices obtained from the pricing service. The Company obtains an understanding of the pricing service's valuation methodologies and related inputs, which include, but are not limited to, reported trades, benchmark yields, issuer spreads, bids, offers, duration, credit ratings, estimated cash flows and prepayment speeds. The Company validates prices provided by the pricing service by reviewing prices from other pricing sources and analyzing pricing data in certain instances.
The Company has evaluated the various types of securities in its investment portfolio to determine an appropriate fair value hierarchy level based upon trading activity and the observability of market inputs. Level 1 investments include those traded on an active exchange, such as the New York Stock Exchange. Level 2 investments include U.S. Treasury securities, U.S. government-sponsored enterprises, municipal bonds, foreign government, agency, and supranational bonds, mortgage-backed securities and corporate and university debt securities. Level 3 investments include the Company's investments in insurance-linked securities funds that are in run-off, which are not traded on an active exchange and are valued using unobservable inputs.
Fair value for available-for-sale investments and equity securities is measured based upon quoted prices in active markets, if available. Due to variations in trading volumes and the lack of quoted market prices, fixed maturity securities are classified as Level 2 investments. The fair value of fixed maturity securities is normally derived through recent reported trades for identical or similar securities, making adjustments through the reporting date based upon available market observable data previously described. If there are no recent reported trades, the fair value of fixed maturity securities may be derived through the use of matrix pricing or model processes, where future cash flow expectations are developed based upon collateral performance and discounted at an estimated market rate. Significant inputs used to determine the fair value of obligations of states, municipalities and political subdivisions, corporate and university bonds and obligations of foreign governments, agencies and supranationals include reported trades, benchmark yields, issuer spreads, bids, offers, credit information and estimated cash flows. Significant inputs used to determine the fair value of mortgage-backed securities include the type of underlying assets, benchmark yields, prepayment speeds, collateral information, tranche type and volatility, estimated cash flows, credit information, default rates, recovery rates, issuer spreads and the year of issue.
Senior long-term debt and other debt. Senior long-term debt and other debt is carried at amortized cost with the estimated fair value disclosed on the consolidated balance sheets. Senior long-term debt and other debt is classified as Level 2 within the fair value hierarchy due to variations in trading volumes and the lack of quoted market prices. The Company determines fair value through a third-party pricing service and generally does not adjust the prices obtained from the pricing service. The Company obtains an understanding of the pricing service's valuation methodologies and related inputs, which include, but are not limited to, reported trades, benchmark yields, issuer spreads, bids, offers, duration, credit ratings and estimated cash flows.
17
Table of Contents
The following tables present the balances of assets measured at fair value on a recurring basis by level within the fair value hierarchy.
| June 30, 2025 | |||||||||||||||||||||||
| (dollars in thousands) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||
| Assets: | |||||||||||||||||||||||
| Investments: | |||||||||||||||||||||||
| Fixed maturity securities, available-for-sale: | |||||||||||||||||||||||
| U.S. Treasury securities | $ | $ | $ | $ | |||||||||||||||||||
| U.S. government-sponsored enterprises | |||||||||||||||||||||||
| Obligations of states, municipalities and political subdivisions | |||||||||||||||||||||||
Foreign governments, agencies and supranationals | |||||||||||||||||||||||
Agency mortgage-backed securities | |||||||||||||||||||||||
Non-agency mortgage-backed securities | |||||||||||||||||||||||
Corporate and university bonds | |||||||||||||||||||||||
| Total fixed maturity securities, available-for-sale | |||||||||||||||||||||||
| Equity securities: | |||||||||||||||||||||||
| Insurance, banks and other financial institutions | |||||||||||||||||||||||
| Industrial, consumer and all other | |||||||||||||||||||||||
| Total equity securities | |||||||||||||||||||||||
| Short-term investments, available-for-sale | |||||||||||||||||||||||
| Total investments | $ | $ | $ | $ | |||||||||||||||||||
| December 31, 2024 | |||||||||||||||||||||||
| (dollars in thousands) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||
| Assets: | |||||||||||||||||||||||
| Investments: | |||||||||||||||||||||||
| Fixed maturity securities, available-for-sale: | |||||||||||||||||||||||
| U.S. Treasury securities | $ | $ | $ | $ | |||||||||||||||||||
| U.S. government-sponsored enterprises | |||||||||||||||||||||||
| Obligations of states, municipalities and political subdivisions | |||||||||||||||||||||||
Foreign governments, agencies and supranationals | |||||||||||||||||||||||
Agency mortgage-backed securities | |||||||||||||||||||||||
Non-agency mortgage-backed securities | |||||||||||||||||||||||
Corporate and university bonds | |||||||||||||||||||||||
| Total fixed maturity securities, available-for-sale | |||||||||||||||||||||||
| Equity securities: | |||||||||||||||||||||||
| Insurance, banks and other financial institutions | |||||||||||||||||||||||
| Industrial, consumer and all other | |||||||||||||||||||||||
| Total equity securities | |||||||||||||||||||||||
| Short-term investments, available-for-sale | |||||||||||||||||||||||
| Total investments | $ | $ | $ | $ | |||||||||||||||||||
Except as disclosed in note 3, the Company did not
18
Table of Contents
6. Products, Services and Other Revenues
The following tables present revenues from contracts with customers by type, all of which are included in products revenues and services and other revenues, along with a reconciliation to total products revenues and services and other revenues.
| Quarter Ended June 30, | |||||||||||||||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||||||||||||||
| (dollars in thousands) | Markel Ventures | Other | Total | Markel Ventures | Other | Total | |||||||||||||||||||||||||||||
| Products | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| Services | |||||||||||||||||||||||||||||||||||
Management fees | |||||||||||||||||||||||||||||||||||
| Total revenues from contracts with customers | |||||||||||||||||||||||||||||||||||
| Leasing revenues | |||||||||||||||||||||||||||||||||||
Fronting fees | |||||||||||||||||||||||||||||||||||
Equity method and other investments income | |||||||||||||||||||||||||||||||||||
| Other | ( | ( | |||||||||||||||||||||||||||||||||
Total products, services and other revenues | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| Six Months Ended June 30, | |||||||||||||||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||||||||||||||
| (dollars in thousands) | Markel Ventures | Other | Total | Markel Ventures | Other | Total | |||||||||||||||||||||||||||||
| Products | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| Services | |||||||||||||||||||||||||||||||||||
Management fees | |||||||||||||||||||||||||||||||||||
| Total revenues from contracts with customers | |||||||||||||||||||||||||||||||||||
| Leasing revenues | |||||||||||||||||||||||||||||||||||
Fronting fees | |||||||||||||||||||||||||||||||||||
Equity method and other investments income | |||||||||||||||||||||||||||||||||||
| Other | ( | ( | |||||||||||||||||||||||||||||||||
Total products, services and other revenues | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Receivables from contracts with customers were $814.8 million and $593.8 million as of June 30, 2025 and December 31, 2024, respectively.
19
Table of Contents
7. Unpaid Losses and Loss Adjustment Expenses
The following table presents a reconciliation of consolidated beginning and ending reserves for losses and loss adjustment expenses.
| Six Months Ended June 30, | |||||||||||
| (dollars in thousands) | 2025 | 2024 | |||||||||
| Gross reserves for losses and loss adjustment expenses, beginning of year | $ | $ | |||||||||
| Reinsurance recoverables on unpaid losses, beginning of year | |||||||||||
| Net reserves for losses and loss adjustment expenses, beginning of year | |||||||||||
| Effect of foreign currency rate changes on beginning of year balance | ( | ||||||||||
| Adjusted net reserves for losses and loss adjustment expenses, beginning of year | |||||||||||
| Incurred losses and loss adjustment expenses: | |||||||||||
| Current accident year | |||||||||||
| Prior accident years | ( | ( | |||||||||
| Total incurred losses and loss adjustment expenses | |||||||||||
| Payments: | |||||||||||
| Current accident year | |||||||||||
| Prior accident years | |||||||||||
| Total payments | |||||||||||
| Effect of foreign currency rate changes on current year activity | ( | ||||||||||
Change in net reserves for losses and loss adjustment expenses of Markel CATCo Re | ( | ( | |||||||||
| Net reserves for losses and loss adjustment expenses, end of period | |||||||||||
| Reinsurance recoverables on unpaid losses | |||||||||||
| Gross reserves for losses and loss adjustment expenses, end of period | $ | $ | |||||||||
For the six months ended June 30, 2025, current accident year losses and loss adjustment expenses included $60.9 million of net losses and loss adjustment expenses attributed to the series of wildfires that occurred in southern California in January 2025 (California Wildfires). The net losses and loss adjustment expenses attributed to the California Wildfires as of June 30, 2025 represent the Company's best estimate based upon information currently available. This loss estimate was based on claims received, policy level reviews and an analysis of ceded reinsurance contracts. The Company's estimate is based on various assumptions about coverage and liability and is therefore subject to change. While the Company believes its net reserves for the California Wildfires as of June 30, 2025 are adequate, it continues to closely monitor reported claims and may adjust the estimate of ultimate net losses as new information becomes available.
For the six months ended June 30, 2025, losses and loss adjustment expenses included $228.8 million of favorable development on prior years loss reserves, which included $177.9 million of net favorable development on the Company's marine and energy, property, professional liability and workers' compensation product lines within its Markel Insurance segment. Favorable development on the Markel Insurance segment's professional liability product lines was net of $127.9 million of adverse development on run-off risk-managed directors and officers product lines.
For the six months ended June 30, 2024, losses and loss adjustment expenses included $221.3 million of favorable development on prior years loss reserves, which included $165.7 million of net favorable development on the Company's international professional liability and marine and energy product lines, as well as its property product lines, within its Markel Insurance segment.
20
Table of Contents
8. Reinsurance
The following tables summarize the effect of reinsurance and retrocessional reinsurance on premiums written and earned. Fronting premiums are attributable to business written on behalf of third-party capacity providers, substantially all of which are ceded.
| Quarter Ended June 30, | |||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||||||||||||||||||||||||||
| (dollars in thousands) | Direct | Assumed | Ceded | Net Premiums | Direct | Assumed | Ceded | Net Premiums | |||||||||||||||||||||||||||||||||||||||
| Underwriting: | |||||||||||||||||||||||||||||||||||||||||||||||
| Written | $ | $ | $ | ( | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||||||||||
| Earned | $ | $ | $ | ( | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||||||||||
Fronting: | |||||||||||||||||||||||||||||||||||||||||||||||
| Written | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Earned | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Consolidated: | |||||||||||||||||||||||||||||||||||||||||||||||
| Written | $ | $ | $ | ( | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||||||||||
| Earned | $ | $ | $ | ( | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||||||||||
| Six Months Ended June 30, | |||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||||||||||||||||||||||||||
| (dollars in thousands) | Direct | Assumed | Ceded | Net Premiums | Direct | Assumed | Ceded | Net Premiums | |||||||||||||||||||||||||||||||||||||||
| Underwriting: | |||||||||||||||||||||||||||||||||||||||||||||||
| Written | $ | $ | $ | ( | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||||||||||
| Earned | $ | $ | $ | ( | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||||||||||
Fronting: | |||||||||||||||||||||||||||||||||||||||||||||||
| Written | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Earned | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
| Consolidated: | |||||||||||||||||||||||||||||||||||||||||||||||
| Written | $ | $ | $ | ( | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||||||||||
| Earned | $ | $ | $ | ( | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||||||||||
| Quarter Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
Ceded earned premiums to gross earned premiums | % | % | % | % | |||||||||||||||||||
Assumed earned premiums to net earned premiums | % | % | % | % | |||||||||||||||||||
Substantially all of the incurred losses and loss adjustment expenses related to the Company's fronted premiums were ceded. These gross losses totaled $1.3 billion and $2.3 billion for the quarter and six months ended June 30, 2025, respectively, and $593.9 million and $1.2 billion for the quarter and six months ended June 30, 2024.
The following table summarizes the effect of reinsurance and retrocessional reinsurance on losses and loss adjustment expenses in the Company's underwriting operations.
| Quarter Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (dollars in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Gross losses and loss adjustment expenses | $ | $ | $ | $ | |||||||||||||||||||
| Ceded losses and loss adjustment expenses | ( | ( | ( | ( | |||||||||||||||||||
| Net losses and loss adjustment expenses | $ | $ | $ | $ | |||||||||||||||||||
21
Table of Contents
9. Related Party Transactions
The Company engages in certain related party transactions in the normal course of business at arm's length.
Fund Management
The Company provides investment and insurance management services through Nephila Holdings Ltd. (together with its subsidiaries, Nephila). Nephila serves as the investment manager to several Bermuda based private funds (the Nephila Funds). To provide access for the Nephila Funds to a variety of insurance-linked securities in the property catastrophe, climate and specialty insurance markets, Nephila also acts as an insurance manager to certain Bermuda licensed reinsurers and as the managing agent to Lloyd's Syndicate 2357 and Lloyd's Syndicate 2358 (collectively, the Nephila Reinsurers). Neither the Nephila Funds nor the Nephila Reinsurers are consolidated by the Company. Nephila receives management fees for investment and insurance management services based on either the net asset value of the accounts managed or gross premium volume for the underlying risks to which the investors subscribed. Nephila also may earn incentive fees from certain funds based on annual performance. For the quarter and six months ended June 30, 2025, total fund management revenues attributed to unconsolidated entities managed by Nephila were $29.1 million and $54.6 million, respectively. For the quarter and six months ended June 30, 2024, total fund management revenues attributed to unconsolidated entities managed by Nephila were $21.8 million and $41.1 million, respectively.
Fronting
The Company engages in fronting activities in both its State National business and its Markel Insurance business. Within both of these businesses, the Company's fronting activities include programs with the Nephila Reinsurers through which the Company writes insurance policies that are fully ceded to the Nephila Reinsurers in exchange for fronting fees. Through these programs, Nephila utilizes certain of the Company's licensed insurance companies to write a portion of its portfolio of U.S. catastrophe-exposed property and specialty risks. Gross premiums written through these programs that were ceded to the Nephila Reinsurers were $1.3 1.7 741.7 1.1
As of June 30, 2025 and December 31, 2024, reinsurance recoverables on the consolidated balance sheets included $986.2 million and $968.9 million, respectively, due from the Nephila Reinsurers. Under its programs with the Nephila Reinsurers, the Company bears underwriting risk for annual aggregate agreement year losses in excess of a limit the Company believes is unlikely to be exceeded. To the extent losses under these programs exceed the prescribed limits, the Company is obligated to pay such losses to the cedents without recourse to the Nephila Reinsurers. While the Company believes losses under these programs are unlikely, those losses, if incurred, could be material to the Company's consolidated results of operations and financial condition.
Beginning in the second quarter of 2024, in order for the Nephila Reinsurers to obtain reinsurance protection for a portion of their exposures, the Company also fronted ceded reinsurance contracts, primarily in the form of industry loss warranties, for the Nephila Reinsurers. Through this arrangement, the underlying risk of the Nephila Reinsurers was retroceded back to the Company and then fully ceded to third-party reinsurers. For the quarter and six months ended June 30, 2025, the Company's gross written premiums from the Nephila Reinsurers under this fronting program were $60.5 74.2 168.0
The Company has also entered into other assumed and ceded reinsurance transactions with the Nephila Reinsurers in the normal course of business, which are not material to the Company's consolidated financial statements.
Hagerty
The Company holds a minority ownership interest in Hagerty, Inc. (Hagerty), which operates primarily as a managing general agent focused on the global automobile enthusiast market and also includes Hagerty Reinsurance Limited (Hagerty Re), a Bermuda Class 3 reinsurance company. Through the Company's underwriting operations, the Company underwrites insurance for Hagerty, a portion of which is ceded to Hagerty Re.
22
Table of Contents
The amounts attributed to these arrangements are summarized in the following table.
| Quarter Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (dollars in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
Gross written premiums attributable to Hagerty | $ | $ | $ | $ | |||||||||||||||||||
Premiums ceded to Hagerty Re | $ | $ | $ | $ | |||||||||||||||||||
As of June 30, 2025 and December 31, 2024, reinsurance recoverables on the consolidated balance sheets included $314.7 million and $308.8 million, respectively, due from Hagerty Re.
10. Shareholders' Equity
a) The Company has 50,000,000 shares of no par value common stock authorized. The following table presents a rollforward of changes in common shares issued and outstanding.
| Quarter Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
(shares in ones) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Issued and outstanding common shares, beginning of period | |||||||||||||||||||||||
| Issuance of common shares | |||||||||||||||||||||||
| Repurchase of common shares | ( | ( | ( | ( | |||||||||||||||||||
| Issued and outstanding common shares, end of period | |||||||||||||||||||||||
b) The Company also has 10,000,000 shares of no par value preferred stock authorized, of which 600,000 600,000 6.00 % Fixed-Rate Reset Non-Cumulative Series A preferred shares for $1,000 per share, for an aggregate value of $600.0 million. At June 30, 2025, none of the Company's preferred shares were issued and outstanding. The Company declared and paid dividends on outstanding preferred shares of $18.0 30
c) Net income per common share was determined by dividing adjusted net income to common shareholders by the applicable weighted average common shares outstanding. Weighted average basic common shares outstanding include restricted stock units that are no longer subject to any contingencies for issuance, but for which corresponding shares have not been issued. Diluted net income per common share is computed by dividing adjusted net income to common shareholders by the weighted average number of common shares and dilutive potential common shares outstanding during the period. The following table presents basic net income per common share and diluted net income per common share.
| Quarter Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (in thousands, except per share amounts) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Net income to common shareholders | $ | $ | $ | $ | |||||||||||||||||||
Adjustment and purchase of redeemable noncontrolling interests | ( | ( | |||||||||||||||||||||
| Adjusted net income to common shareholders | $ | $ | $ | $ | |||||||||||||||||||
Weighted average basic common shares outstanding | |||||||||||||||||||||||
Weighted average dilutive potential common shares from restricted stock units and restricted stock | |||||||||||||||||||||||
Weighted diluted common shares outstanding | |||||||||||||||||||||||
| Basic net income per common share | $ | $ | $ | $ | |||||||||||||||||||
Diluted net income per common share | $ | $ | $ | $ | |||||||||||||||||||
11. Contingencies
Contingencies arise in the normal course of the Company's operations and are not expected to have a material impact on the Company's financial condition or results of operations.
23
Table of Contents
12. Subsequent Event
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis should be read in conjunction with the consolidated financial statements and related notes included under Item 1 Financial Statements and our 2024 Annual Report on Form 10-K. The accompanying consolidated financial statements and related notes have been prepared in accordance with United States (U.S.) generally accepted accounting principles (GAAP) and include the accounts of our holding company, Markel Group Inc. (Markel Group), and its consolidated subsidiaries, as well as any variable interest entities that meet the requirements for consolidation. This section is divided into the following sections:
•Business Overview
•Results of Operations
•Financial Condition
•Critical Accounting Estimates
•Safe Harbor and Cautionary Statement
Business Overview
Markel Group is a holding company comprised of a diverse family of businesses and investments. The leadership teams of our businesses operate with a high degree of independence, while at the same time living the values that we call the Markel Style. Our specialty insurance business, Markel Insurance, sits at the core of our company. Through decades of sound underwriting, Markel Insurance has provided the capital base from which we built a system of businesses and investments that collectively increase Markel Group's durability and adaptability. We aspire to build one of the world's great companies by creating win-win-win outcomes for our customers, associates and shareholders. We deploy three financial engines in pursuit of this goal.
Insurance - markets and underwrites specialty insurance products
Investments - invests capital held within our insurance operations, as well as capital allocated by Markel Group, in fixed maturity and equity securities
Markel Ventures - owns controlling interests in a diverse portfolio of businesses that operate in a variety of industries
Our businesses provide a diverse set of income streams, access to a wide range of investment opportunities and the ability to efficiently move capital to the best ideas across our family of businesses. We allocate capital using a process that we have consistently followed for years. We first look to invest in our existing businesses for organic growth opportunities. After funding internal growth opportunities, we look to acquire controlling interests in businesses, build our portfolio of equity securities or repurchase shares of our common stock. We believe our system is uniquely equipped for long-term growth.
To mitigate the effects of short-term volatility and align with the long-term perspective that we apply to operating our businesses and making investments, we generally use five-year time periods to measure our performance. We measure financial success using both operating income and total shareholder return. Operating income provides a reasonable proxy for the performance of each engine in support of our overall financial goal of growing intrinsic value.
24
Table of Contents
Insurance
Our insurance operations are comprised of the following businesses:
•Markel Insurance - global specialty insurer
•State National - automobile collateral protection coverage and fronting services provider
•Nephila - insurance-linked securities (ILS) investment manager
We hold significant capital within our insurance operations to support the capital requirements of our underwriting subsidiaries, which is available for investment and generates both recurring streams of net investment income and investment returns. The invested assets held by our insurance subsidiaries are managed by, and reported through, our Investments engine, separate from our insurance operations.
Within our insurance operations, we have a suite of capabilities through which we can access capital to support our customers' risks, which includes our own capital, as well as third-party capital through our State National and Nephila businesses. We seek to differentiate ourselves from competitors by our specialized product expertise, exceptional customer service, continuity and other value-based considerations, including the multiple platforms through which we can manage risk and deploy capital. For example, we leverage the capabilities of our highly rated underwriting subsidiaries to front reinsurance contracts in support of Nephila's business plans. Additionally, in 2024, State National partnered with Markel Insurance's International division to expand State National's fronting services internationally.
Markel Insurance
Markel Insurance is a specialty insurance business comprised of a network of subsidiaries that underwrite hard-to-place risks across the globe. Markel Insurance's business is organized into four divisions: U.S. Wholesale and Specialty, Programs and Solutions, International and Global Reinsurance. These divisions underwrite a variety of specialty insurance products and also include certain other insurance-related operations and strategic investments that complement and support the underwriting activities. Markel Insurance also includes the run-off of certain business previously written on its underwriting subsidiaries that are not managed through these divisions. These include the discontinued intellectual property collateral protection insurance (IP CPI) product line, life and annuity reinsurance business and certain asbestos and environmental exposures. In evaluating the overall returns of our Markel Insurance business, we consider the operating income from underwriting activities included in our Markel Insurance segment, as well as the investment earnings on the capital held by its underwriting subsidiaries, which are included in our Investing segment.
The U.S. Wholesale and Specialty division is Markel Insurance's core U.S. specialty insurance business, which includes business written through both wholesale and retail channels on both an excess and surplus and admitted basis. Principal lines of business include general liability, professional liability and property, all of which we also offer on a binding authority basis.
The Programs and Solutions division offers a portfolio of highly specialized insurance products in the U.S., including personal lines, programs and partnerships, credit and surety coverages, workers' compensation and small commercial lines, as well as specialty lines written from its Bermuda platform. The Programs and Solutions division also provides fronting services for Nephila in support of their insurance-linked securities fund management operations and the portfolio of risks assumed by their investors.
The International division offers specialty insurance products outside of the U.S. and Bermuda, operating in 15 countries across the globe. Principal lines of business include marine and energy, professional liability, general liability, credit and surety, property and other coverages tailored for unique exposures.
The Global Reinsurance division includes casualty and specialty reinsurance products offered to other insurance and reinsurance companies. Principal lines of business include general liability, professional liability, marine and energy, workers' compensation and credit and surety.
On July 30, 2025, Markel Insurance announced an agreement to sell the renewal rights for its Global Reinsurance business. In conjunction with the transaction, which is expected to close in August 2025, the Global Reinsurance division will enter into run-off. The transaction is subject to customary closing conditions. The Global Reinsurance division's gross premium volume in 2024 was $1.2 billion. As many of the contracts written within this division are multi-year agreements, we expect premiums to continue earning over the next two to three years and loss reserves are expected to take several additional years to run off.
25
Table of Contents
State National
Our State National business consists of program services and lender services operations. The program services operations generate fee revenues in the form of ceding fees in exchange for fronting insurance and reinsurance business for other insurance carriers. The lender services operations write collateral protection insurance on a risk-bearing basis for automobile and other vehicle loans in the U.S. The results of our State National business are reported within our other insurance operations and are not included in a reportable segment.
Although we reinsure substantially all of the risks inherent in our program services operations, we have certain programs that contain limits on our reinsurers' obligations to us that expose us to underwriting risk, including loss ratio caps, aggregate reinsurance limits or exclusion of the credit risk of producers. Under certain programs, we also bear underwriting risk for annual aggregate agreement year losses in excess of a limit that we believe is unlikely to be exceeded.
Nephila
Nephila Holdings Ltd. (together with its subsidiaries, Nephila) provides insurance-linked securities investment and insurance management services to investors through which it offers alternative capital to the insurance and reinsurance markets while providing the investors with investment strategies that typically are uncorrelated with traditional asset classes. Nephila generates fee revenues in the form of management fees for investment management services. The results of Nephila are reported within our other insurance operations and are not included in a reportable segment.
See note 9 of the notes to consolidated financial statements for further details regarding transactions with entities managed through our Nephila operations, which include several Bermuda-based private funds (the Nephila Funds) and Bermuda-licensed reinsurers and Lloyd's syndicates (collectively, the Nephila Reinsurers).
Investments
Our investment operations manage the capital held within our insurance operations, as well as capital held by the Markel Group holding company. Invested assets managed through our investment operations include our portfolio of publicly traded fixed maturity and equity securities, as well as cash and short-term investments. Substantially all of our investment portfolio is managed by company employees, which helps minimize costs in our investment operations.
Our insurance operations provide our investment operations with steady inflows of premiums. These funds are invested predominantly in high-quality government and municipal bonds and mortgage-backed securities that generally match the duration and currency of our loss reserves. We typically hold these investments until maturity. As a result, unrealized holding gains and losses on these securities are generally expected to reverse as the securities mature. Premiums collected through our insurance operations may also be held as short-term investments or cash and cash equivalents to provide short-term liquidity for projected claims payments, reinsurance costs and operating expenses.
Capital held by our insurance subsidiaries beyond that which we anticipate will be needed to cover claims payments and operating expenses, as well as capital allocated for investment purposes by Markel Group, is available to be invested in equity securities. When purchasing equity securities, we seek to invest in profitable companies with high returns on capital and low debt, with honest and talented management and significant reinvestment opportunities and capital discipline, all while paying reasonable prices for those securities. We intend to hold these equity investments over the long term. Over the long run, equity securities have produced higher returns relative to fixed maturity securities and short-term investments. Our investments in equity securities are predominantly held within our regulated insurance subsidiaries to support capital requirements. We allocate a higher percentage of capital within our regulated insurance subsidiaries to equity securities than most other insurance companies.
26
Table of Contents
Markel Ventures
Through our wholly owned subsidiary Markel Ventures, Inc. (Markel Ventures), we own controlling interests in high-quality, specialized businesses that operate in a variety of different industries with shared values and the goal of positively contributing to the long-term financial performance of Markel Group. Management teams for each business operate autonomously and are responsible for developing strategic initiatives, managing day-to-day operations and making investment and capital allocation decisions for their respective companies. Our Markel Group management team is responsible for decisions regarding allocation of capital for acquisitions and new investments. Our strategy in making these acquisitions is similar to our strategy for purchasing equity securities. We seek to invest in profitable companies, with honest and talented management, that exhibit reinvestment opportunities and capital discipline, at reasonable prices. We intend to own the businesses acquired for a long period of time.
Our chief operating decision maker allocates resources to and assesses the performance of these various businesses in the aggregate as the Markel Ventures segment. The following types of businesses are included in this segment: construction services, consumer and building products, transportation-related products, equipment manufacturing products and consulting services. These businesses offer various types of products and services to businesses and consumers across many markets. All of our businesses in this segment are headquartered in the U.S., with subsidiaries of certain businesses located outside of the U.S.
In June 2024, we acquired a majority interest in Valor Environmental (Valor), an environmental services company providing erosion control and related services to commercial development sites and homebuilders throughout the U.S. In September 2024, we acquired a majority ownership interest in Educational Partners International (EPI), a company that sponsors international teachers for placements in schools in the U.S. Through January 15, 2025, our investment in EPI was accounted for under the equity method, as we did not have control over the business due to regulatory approval that was still pending. On January 16, 2025, we received regulatory approval, which resulted in control and consolidation of EPI. See note 3 of the notes to consolidated financial statements for additional details related to these acquisitions.
27
Table of Contents
Results of Operations
The following table presents the components of operating revenues.
| Quarter Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (dollars in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
Markel Insurance segment | $ | 2,070,215 | $ | 2,010,477 | $ | 4,091,058 | $ | 4,061,337 | |||||||||||||||
Other insurance operations | 161,852 | 137,791 | 328,822 | 272,649 | |||||||||||||||||||
| Insurance operations | 2,232,067 | 2,148,268 | 4,419,880 | 4,333,986 | |||||||||||||||||||
Net investment income | 228,126 | 220,454 | 463,727 | 437,658 | |||||||||||||||||||
| Net investment gains (losses) | 580,223 | (130,017) | 431,152 | 772,264 | |||||||||||||||||||
| Other | 14,064 | 9,357 | 9,454 | 30,203 | |||||||||||||||||||
| Investing segment | 822,413 | 99,794 | 904,333 | 1,240,125 | |||||||||||||||||||
| Markel Ventures segment | 1,548,286 | 1,453,781 | 2,677,658 | 2,594,387 | |||||||||||||||||||
| Total operating revenues | $ | 4,602,766 | $ | 3,701,843 | $ | 8,001,871 | $ | 8,168,498 | |||||||||||||||
The following table presents the components of operating income and comprehensive income to shareholders.
| Quarter Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (dollars in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
Operating income: | |||||||||||||||||||||||
Markel Insurance segment | $ | 60,337 | $ | 123,896 | $ | 136,619 | $ | 218,624 | |||||||||||||||
Other insurance operations | 68,075 | 53,029 | 136,829 | 94,126 | |||||||||||||||||||
Insurance operations | 128,412 | 176,925 | 273,448 | 312,750 | |||||||||||||||||||
Investing segment | 822,413 | 99,794 | 904,333 | 1,240,125 | |||||||||||||||||||
Markel Ventures segment | 207,728 | 177,498 | 310,238 | 281,413 | |||||||||||||||||||
Amortization of acquired intangible assets | (51,213) | (44,237) | (98,155) | (88,522) | |||||||||||||||||||
Operating income | 1,107,340 | 409,980 | 1,389,864 | 1,745,766 | |||||||||||||||||||
| Interest expense | (53,076) | (52,597) | (105,216) | (98,145) | |||||||||||||||||||
| Net foreign exchange gains (losses) | (191,909) | 8,711 | (264,542) | 60,211 | |||||||||||||||||||
| Income tax expense | (185,170) | (76,244) | (213,574) | (368,800) | |||||||||||||||||||
| Net income attributable to noncontrolling interests | (20,037) | (22,149) | (27,670) | (46,147) | |||||||||||||||||||
| Net income to shareholders | 657,148 | 267,701 | 778,862 | 1,292,885 | |||||||||||||||||||
Preferred stock dividends and redemption premiums | (26,109) | (18,000) | (26,109) | (18,000) | |||||||||||||||||||
| Net income to common shareholders | 631,039 | 249,701 | 752,753 | 1,274,885 | |||||||||||||||||||
| Other comprehensive income (loss) to shareholders | 210,363 | (23,345) | 436,319 | (140,144) | |||||||||||||||||||
| Comprehensive income to shareholders | $ | 867,511 | $ | 244,356 | $ | 1,215,181 | $ | 1,152,741 | |||||||||||||||
The change in operating income and comprehensive income to shareholders for the quarter and six month periods was driven by the differences in unrealized gains and losses on our equity securities across the periods. Additionally, the change in comprehensive income to shareholders was driven by the difference in unrealized gains and losses on our fixed maturity securities across the periods.
The components of comprehensive income to shareholders are discussed in further detail under "Insurance Results," "Investing Results," "Markel Ventures Results," "Other" and "Other Comprehensive Income (Loss) to Shareholders."
28
Table of Contents
Insurance Results
Our insurance operations include our Markel Insurance business, as well as our other insurance operations, which are primarily comprised of our State National and Nephila businesses.
Underwriting profits are a key component of our strategy to build shareholder value through our Markel Insurance business. The property and casualty insurance industry commonly defines underwriting profit or loss as earned premiums net of losses and loss adjustment expenses and underwriting, acquisition and insurance expenses. We use underwriting profit or loss and the combined ratio as a basis for evaluating our underwriting performance. The U.S. GAAP combined ratio is a measure of underwriting performance and represents the relationship of incurred losses, loss adjustment expenses and underwriting, acquisition and insurance expenses to earned premiums. The combined ratio is the sum of the loss ratio and the expense ratio. The loss ratio represents the relationship of incurred losses and loss adjustment expenses to earned premiums. The expense ratio represents the relationship of underwriting, acquisition and insurance expenses to earned premiums. A combined ratio less than 100% indicates an underwriting profit, while a combined ratio greater than 100% reflects an underwriting loss.
When analyzing our loss ratio, we typically evaluate losses and loss adjustment expenses attributable to the current accident year separate from losses and loss adjustment expenses attributable to prior accident years. Prior accident year reserve development, which can either be favorable or unfavorable, represents changes in our estimates of losses and loss adjustment expenses related to loss events that occurred in prior years. We believe a discussion of current accident year loss ratios that exclude prior accident year reserve development is helpful in most cases since it provides more insight into estimates of current underwriting performance and excludes changes in estimates related to prior year loss reserves.
In addition to the U.S. GAAP combined ratio, loss ratio and expense ratio, we also evaluate our underwriting performance using measures that exclude the impacts of certain items on these ratios. We believe these adjusted measures, which are non‑GAAP measures, provide financial statement users with a better understanding of the significant factors that comprise our underwriting results and how management evaluates underwriting performance.
When analyzing our combined ratio, we exclude current accident year losses and loss adjustment expenses attributed to natural catastrophes and certain other significant, infrequent loss events. Gross and ceded losses for certain events may also result in receipt or payment of reinstatement premiums, which, if significant, may also be excluded when analyzing our combined ratio. Due to the unique characteristics of these events, there is inherent variability as to the timing or amount of the loss, which cannot be predicted in advance. We believe measures that exclude the effects of such events are meaningful to understand the underlying trends and variability in our underwriting results that may be obscured by these items.
We also analyze our current accident year loss ratio excluding losses and loss adjustment expenses attributable to catastrophes. The current accident year loss ratio excluding the impact of catastrophes and other significant, infrequent loss events is also commonly referred to as an attritional loss ratio within the property and casualty insurance industry.
29
Table of Contents
Markel Insurance
| Quarter Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||||||||||||||
| (dollars in thousands) | 2025 | 2024 | % Change | 2025 | 2024 | % Change | |||||||||||||||||||||||||||||
Underwriting | $ | 2,808,823 | $ | 2,852,600 | (2) | % | $ | 5,602,229 | $ | 5,551,048 | 1 | % | |||||||||||||||||||||||
Fronting | 1,293,649 | 811,895 | 59 | % | 1,671,794 | 1,120,724 | 49 | % | |||||||||||||||||||||||||||
| Gross premium volume | $ | 4,102,472 | $ | 3,664,495 | 12 | % | $ | 7,274,023 | $ | 6,671,772 | 9 | % | |||||||||||||||||||||||
| Net written premiums | $ | 2,165,255 | $ | 2,210,144 | (2) | % | $ | 4,403,931 | $ | 4,364,629 | 1 | % | |||||||||||||||||||||||
| Earned premiums | $ | 2,063,622 | $ | 2,004,166 | 3 | % | $ | 4,080,161 | $ | 4,050,645 | 1 | % | |||||||||||||||||||||||
| Underwriting profit | $ | 63,200 | $ | 124,134 | (49) | % | $ | 143,362 | $ | 221,094 | (35) | % | |||||||||||||||||||||||
| Operating income | $ | 60,337 | $ | 123,896 | (51) | % | $ | 136,619 | $ | 218,624 | (38) | % | |||||||||||||||||||||||
Underwriting Ratios (1) | Point Change | Point Change | |||||||||||||||||||||||||||||||||
| Loss ratio | |||||||||||||||||||||||||||||||||||
| Current accident year loss ratio | 64.5 | % | 66.6 | % | (2.1) | 66.0 | % | 65.4 | % | 0.6 | |||||||||||||||||||||||||
| Prior accident years loss ratio | (3.8) | % | (7.2) | % | 3.4 | (5.6) | % | (5.5) | % | (0.1) | |||||||||||||||||||||||||
| Loss ratio | 60.7 | % | 59.3 | % | 1.4 | 60.4 | % | 59.9 | % | 0.5 | |||||||||||||||||||||||||
| Expense ratio | 36.3 | % | 34.5 | % | 1.8 | 36.1 | % | 34.7 | % | 1.4 | |||||||||||||||||||||||||
| Combined ratio | 96.9 | % | 93.8 | % | 3.1 | 96.5 | % | 94.5 | % | 2.0 | |||||||||||||||||||||||||
Current accident year loss ratio catastrophe impact (2) | (0.3) | % | — | % | (0.3) | 1.5 | % | — | % | 1.5 | |||||||||||||||||||||||||
| Current accident year loss ratio, excluding catastrophes impact | 64.7 | % | 66.6 | % | (1.9) | 64.5 | % | 65.4 | % | (0.9) | |||||||||||||||||||||||||
Combined ratio, excluding current year catastrophes impact | 97.2 | % | 93.8 | % | 3.4 | 95.0 | % | 94.5 | % | 0.5 | |||||||||||||||||||||||||
(1) Amounts may not reconcile due to rounding.
(2) The point impact of catastrophes is calculated as the associated net losses and loss adjustment expenses divided by total earned premiums.
Premiums
The modest decrease in underwriting gross premium volume in our Markel Insurance segment for the quarter ended June 30, 2025 was driven by unfavorable timing differences on two large reinsurance contract renewals, as well as the impact of exiting our risk-managed directors and officers product line from our U.S. and Europe-based platforms. We concluded that the rates on the business written from these platforms are inadequate to meet our profitability targets, therefore, we stopped writing this product from these platforms. We continue to write select risk-managed directors and officers accounts from our Bermuda-based platform. These premium decreases were partially offset by the favorable impact of rate increases and new business on our personal lines and general liability product lines.
The modest increase in underwriting gross premium volume in our Markel Insurance segment for the six months ended June 30, 2025 was driven by significant growth within our personal lines product lines, as well as rate increases and new business within our general liability and programs product lines. These increases were largely offset by the impact of unfavorable timing differences on reinsurance contract renewals and lower premium volume in our professional liability product lines, as a result of exiting certain product lines that did not meet our profitability targets, as previously discussed.
For both the quarter and six months ended June 30, 2025, the increase in fronting gross premium volume was driven by growth of our property catastrophe programs with the Nephila Reinsurers.
Net retention of underwriting gross premium volume for both the quarters ended June 30, 2025 and 2024 was 77%. Net retention of underwriting gross premium volume was 79% for both the six months ended June 30, 2025 and 2024. Within our underwriting operations, we purchase reinsurance and retrocessional reinsurance to manage our net retention on individual risks and overall exposure to losses and to enable us to write policies with sufficient limits to meet policyholder needs.
For the quarter and six months ended June 30, 2025, the increase in earned premiums was primarily due to higher premium volume within our personal lines and programs product lines in recent periods.
30
Table of Contents
Rate Discussion
In the first half of 2025, we achieved modest rate increases across our diversified product portfolio. We examine each of our product classes regularly by evaluating pricing and exposure, underwriting terms and conditions, deal structure, including limits and attachment points, and our expectations around loss cost trends, among other things. We target premium growth only in product lines where we are confident in the levels of rate adequacy.
Product lines achieving the most notable rate increases include our U.S. general liability product lines, as well as certain personal lines and programs product lines. We continue to be cautious in selecting which risks to pursue and how much limit to deploy within certain subclasses of our U.S. general liability portfolio as we rebalance our portfolio, however the rate increases have generally been in line with, or better than, our assumptions on loss cost trends. As a result of the rate increases being achieved in our personal lines and programs product lines, we are increasing our premium writings in these lines.
Product lines with notable rate decreases include our workers' compensation, energy and cyber portfolios and, more recently, our U.S. property product lines as market conditions have softened.
Within our professional liability product lines, we are seeing moderate rate decreases on many of our subclasses. In our international professional liability portfolio, we believe the business is adequately priced overall, and we are opportunistically growing premiums within those subclasses where we believe the current rates are sufficient to meet our profitability targets.
Natural Catastrophes
Underwriting results for the six months ended June 30, 2025 included $60.9 million of net losses and loss adjustment expenses attributed to the series of wildfires that occurred in southern California in January 2025 (California Wildfires). In the second quarter of 2025, we reduced our initial estimate of losses attributable to the California Wildfires by $5.2 million as more information became available. While we believe our net reserves for the California Wildfires as of June 30, 2025 are adequate, we continue to closely monitor reported claims and may further adjust our estimate of ultimate net losses as new information becomes available.
Intellectual Property Collateral Protection Insurance
We have continued to recognize losses on our discontinued IP CPI product line in 2025, in amounts consistent with our expectations. For the quarter and six months ended June 30, 2025, net losses and loss adjustment expenses on our IP CPI product line totaled $26.4 million and $42.6 million, respectively, or one point on both the quarter-to-date and year-to-date Markel Insurance segment combined ratios. Net losses and loss adjustment expenses on our IP CPI product line for the quarter and six months ended June 30, 2024 were $56.4 million and $96.8 million, respectively, or three and two points, on the quarter-to-date and year-to-date Markel Insurance segment combined ratios, respectively. We believe the amount of losses on this product line in 2025 will be less than what we recognized in 2024.
Combined Ratio
The Markel Insurance segment's combined ratio for the quarter and six months ended June 30, 2025 was unfavorably impacted by losses attributable to certain lines of business that we have exited.
In the second quarter of 2025, adverse development on prior accident years loss reserves for the run-off U.S. and Europe-based risk-managed directors and officers product lines totaled $127.0 million, or six points and three points, on the quarter-to-date and year-to-date Markel Insurance segment combined ratios, respectively.
In the quarter and six months ended June 30, 2025, adverse development on prior accident years loss reserves attributable to the Global Reinsurance division, which is entering run-off, was $49.5 million and $31.9 million, respectively, which added two points and one point to the quarter-to-date and year-to-date Markel Insurance segment combined ratios, respectively. In the second quarter of 2025, we engaged a third party to perform a review of reserves on the Global Reinsurance division's general liability product lines, which resulted in increases to prior accident years loss reserves, as well as current accident year loss ratios, in order to increase the level of caution in the loss reserves.
Additionally, losses on our discontinued IP CPI product line added one point to both the Markel Insurance 2025 quarter-to-date and year-to-date combined ratios.
31
Table of Contents
Combined Ratio: Quarter-to-Date
The increase in the Markel Insurance segment's combined ratio for the quarter ended June 30, 2025 compared to the same period of 2024 was primarily attributable to less favorable development on prior accident years loss reserves.
The decrease in the Markel Insurance segment's current accident year loss ratio for the quarter ended June 30, 2025 was primarily attributable to lower losses on our discontinued IP CPI product line and a favorable impact from changes in mix of business, as our growing lines of business generally have lower attritional loss ratios than the lines of business for which we have reduced our premium writings.
The Markel Insurance segment's combined ratio for the quarter ended June 30, 2025 included $78.9 million of favorable development on prior accident years loss reserves compared to $145.1 million for the same period of 2024. The decrease in favorable development was primarily attributable to adverse development on our general liability and professional liability product lines in the second quarter of 2025 compared to favorable development in the same period of 2024. Adverse development on our general liability product lines in 2025 was driven by the increases in prior accident years loss reserves within our Global Reinsurance division, as previously discussed. Adverse development on our professional liability product lines in the second quarter of 2025 was driven by our run-off risk-managed directors and officers product lines, as previously discussed, and was most significant on the 2019 to 2023 accident years. These decreases were partially offset by more favorable development on several product lines, most notably our property and marine and energy product lines, in the second quarter of 2025 compared to the same period of 2024.
For the quarter ended June 30, 2025, favorable development was most significant on the more recent accident years within our property and marine and energy product lines. The favorable development on prior years loss reserves in the second quarter of 2024 was most significant on our international professional liability product lines.
The increase in the Markel Insurance segment's expense ratio for the quarter ended June 30, 2025 compared to the same period of 2024 was primarily attributable to higher personnel costs, including increased severance costs related to recent organizational changes, and professional fees, including costs incurred in connection with activist shareholder activities and the Board-led review.
Combined Ratio: Year-to-Date
Excluding losses attributed to natural catastrophes, the modest increase in the Markel Insurance segment's combined ratio for the six months ended June 30, 2025 compared to the same period of 2024 was primarily attributable to a higher expense ratio.
Excluding losses attributed to natural catastrophes, the decrease in the Markel Insurance segment's current accident year loss ratio for the six months ended June 30, 2025 was due to the same factors as discussed on a quarter-to-date basis.
The Markel Insurance segment's combined ratio for the six months ended June 30, 2025 included $227.8 million of favorable development on prior accident years loss reserves compared to $224.1 million for the same period of 2024. For the six months ended June 30, 2025, favorable development was most significant on the more recent accident years within our marine and energy, property, professional liability and workers' compensation product lines. Favorable development on our professional liability product lines in the first half of 2025 was net of adverse development on our run-off risk-managed directors and officers product lines, as previously discussed. Favorable development on prior years loss reserves in the first half of 2024 was most significant on our international professional liability and marine and energy product lines, as well as our property product lines.
The increase in the Markel Insurance segment's expense ratio for the six months ended June 30, 2025 compared to the same period of 2024 was due to the same factors as discussed on a quarter-to-date basis.
32
Table of Contents
Markel Insurance - Divisional Results
The following tables present the divisional results of the Markel Insurance segment.
Quarter-to-Date
| Quarter Ended June 30, 2025 | |||||||||||||||||||||||||||||||||||
| (dollars in thousands) | U.S. Wholesale and Specialty | Programs and Solutions | International | Global Reinsurance | Other | Markel Insurance | |||||||||||||||||||||||||||||
Underwriting | $ | 828,772 | $ | 980,901 | $ | 677,471 | $ | 321,676 | $ | 3 | $ | 2,808,823 | |||||||||||||||||||||||
Fronting | — | 1,293,649 | — | — | — | 1,293,649 | |||||||||||||||||||||||||||||
| Gross premium volume | $ | 828,772 | $ | 2,274,550 | $ | 677,471 | $ | 321,676 | $ | 3 | $ | 4,102,472 | |||||||||||||||||||||||
| Net written premiums | $ | 673,926 | $ | 619,526 | $ | 588,750 | $ | 283,980 | $ | (927) | $ | 2,165,255 | |||||||||||||||||||||||
| Earned premiums | $ | 659,902 | $ | 576,858 | $ | 535,088 | $ | 285,404 | $ | 6,370 | $ | 2,063,622 | |||||||||||||||||||||||
| Losses and loss adjustment expenses: | |||||||||||||||||||||||||||||||||||
| Current accident year - attritional | (448,476) | (363,154) | (272,263) | (226,851) | (25,057) | (1,335,801) | |||||||||||||||||||||||||||||
| Current accident year - catastrophe | (60) | (253) | 5,000 | 500 | — | 5,187 | |||||||||||||||||||||||||||||
| Prior accident years | 2,516 | 51,808 | 75,144 | (49,534) | (1,000) | 78,934 | |||||||||||||||||||||||||||||
Underwriting, acquisition and insurance expenses | (224,447) | (215,154) | (223,246) | (82,844) | (3,051) | (748,742) | |||||||||||||||||||||||||||||
| Underwriting profit (loss) | $ | (10,565) | $ | 50,105 | $ | 119,723 | $ | (73,325) | $ | (22,738) | $ | 63,200 | |||||||||||||||||||||||
| Services and other revenues | — | 5,824 | 829 | — | (60) | 6,593 | |||||||||||||||||||||||||||||
| Services and other expenses | — | (2,365) | (2,543) | — | (4,548) | (9,456) | |||||||||||||||||||||||||||||
| Operating income (loss) | $ | (10,565) | $ | 53,564 | $ | 118,009 | $ | (73,325) | $ | (27,346) | $ | 60,337 | |||||||||||||||||||||||
| Current accident year loss ratio | 68.0 | % | 63.0 | % | 49.9 | % | 79.3 | % | 64.5 | % | |||||||||||||||||||||||||
| Prior accident years loss ratio | (0.4) | % | (9.0) | % | (14.0) | % | 17.4 | % | (3.8) | % | |||||||||||||||||||||||||
| Loss ratio | 67.6 | % | 54.0 | % | 35.9 | % | 96.7 | % | 60.7 | % | |||||||||||||||||||||||||
| Expense ratio | 34.0 | % | 37.3 | % | 41.7 | % | 29.0 | % | 36.3 | % | |||||||||||||||||||||||||
| Combined ratio | 101.6 | % | 91.3 | % | 77.6 | % | 125.7 | % | 96.9 | % | |||||||||||||||||||||||||
| Quarter Ended June 30, 2024 | |||||||||||||||||||||||||||||||||||
| (dollars in thousands) | U.S. Wholesale and Specialty | Programs and Solutions | International | Global Reinsurance | Other | Markel Insurance | |||||||||||||||||||||||||||||
Underwriting | $ | 873,528 | $ | 912,458 | $ | 646,621 | $ | 436,220 | $ | (16,227) | $ | 2,852,600 | |||||||||||||||||||||||
Fronting | — | 811,895 | — | — | — | 811,895 | |||||||||||||||||||||||||||||
| Gross premium volume | $ | 873,528 | $ | 1,724,353 | $ | 646,621 | $ | 436,220 | $ | (16,227) | $ | 3,664,495 | |||||||||||||||||||||||
| Net written premiums | $ | 674,649 | $ | 575,168 | $ | 546,304 | $ | 415,166 | $ | (1,143) | $ | 2,210,144 | |||||||||||||||||||||||
| Earned premiums | $ | 701,226 | $ | 538,522 | $ | 480,665 | $ | 276,071 | $ | 7,682 | $ | 2,004,166 | |||||||||||||||||||||||
| Losses and loss adjustment expenses: | |||||||||||||||||||||||||||||||||||
| Current accident year - attritional | (482,136) | (340,960) | (263,419) | (195,641) | (52,384) | (1,334,540) | |||||||||||||||||||||||||||||
| Current accident year - catastrophe | — | — | — | — | — | — | |||||||||||||||||||||||||||||
| Prior accident years | 18,024 | 32,795 | 101,864 | (3,728) | (3,820) | 145,135 | |||||||||||||||||||||||||||||
Underwriting, acquisition and insurance expenses | (231,793) | (182,300) | (197,237) | (77,307) | (1,990) | (690,627) | |||||||||||||||||||||||||||||
| Underwriting profit (loss) | $ | 5,321 | $ | 48,057 | $ | 121,873 | $ | (605) | $ | (50,512) | $ | 124,134 | |||||||||||||||||||||||
| Services and other revenues | — | 4,850 | 1,810 | — | (349) | 6,311 | |||||||||||||||||||||||||||||
| Services and other expenses | — | (1,048) | (2,505) | — | (2,996) | (6,549) | |||||||||||||||||||||||||||||
| Operating income (loss) | $ | 5,321 | $ | 51,859 | $ | 121,178 | $ | (605) | $ | (53,857) | $ | 123,896 | |||||||||||||||||||||||
| Current accident year loss ratio | 68.8 | % | 63.3 | % | 54.8 | % | 70.9 | % | 66.6 | % | |||||||||||||||||||||||||
| Prior accident years loss ratio | (2.6) | % | (6.1) | % | (21.2) | % | 1.4 | % | (7.2) | % | |||||||||||||||||||||||||
| Loss ratio | 66.2 | % | 57.2 | % | 33.6 | % | 72.2 | % | 59.3 | % | |||||||||||||||||||||||||
| Expense ratio | 33.1 | % | 33.9 | % | 41.0 | % | 28.0 | % | 34.5 | % | |||||||||||||||||||||||||
| Combined ratio | 99.2 | % | 91.1 | % | 74.6 | % | 100.2 | % | 93.8 | % | |||||||||||||||||||||||||
33
Table of Contents
U.S. Wholesale and Specialty
The 5% decrease in gross premium volume and 6% decrease in earned premiums within the U.S. Wholesale and Specialty division for the quarter ended June 30, 2025 was primarily due to the impact of exiting our U.S. risk-managed directors and officers product line from this platform. The U.S. Wholesale and Specialty division's combined ratio for the quarter ended June 30, 2025 increased two points primarily due to less favorable development on prior accident years loss reserves. In the second quarter of 2025, adverse development on our run-off U.S. risk-managed directors and officers product line was $89.8 million, or 14 points on the U.S. Wholesale and Specialty combined ratio.
Programs and Solutions
The 8% increase in underwriting gross premium volume and 7% increase in earned premiums within the Programs and Solutions division for the quarter ended June 30, 2025 was driven by more favorable rates and new business within our personal lines product lines, partially offset by the impact of exiting our European risk-managed directors and officers product line. The significant growth in fronting gross premium volume was driven by expansion of our property catastrophe programs with the Nephila Reinsurers.
The Programs and Solutions division's combined ratio for the quarter ended June 30, 2025 was consistent with the second quarter of 2024 at 91% as the impact of more favorable development on prior accident years loss reserves was offset by a higher expense ratio. Favorable development in the second quarter of 2025 was net of $37.2 million, or six points on the Programs and Solutions combined ratio, of adverse development on our run-off European risk-managed directors and officers product line.
International
The 5% increase in gross premium volume within the International division for the quarter ended June 30, 2025 was driven by modest increases on our general liability, professional liability and equine product lines. The 11% increase in earned premiums was driven by higher premium volume in recent periods across the portfolio. The International division's combined ratio for the quarter ended June 30, 2025 increased three points primarily due to less favorable development on prior accident years loss reserves, partially offset by a lower current accident year loss ratio.
Global Reinsurance
Gross premium volume within the Global Reinsurance division for the quarter ended June 30, 2025 decreased by 26% due to unfavorable timing differences on the renewal of two large contracts within our professional liability product lines, which were renewed in the second quarter of 2024 and the third quarter of 2025. These contracts had notable renewal decreases when renewed in the third quarter of 2025. Significant variability in gross premium volume can be expected in the Global Reinsurance division due to individually significant contracts and multi-year contracts.
The Global Reinsurance division's combined ratio for the quarter ended June 30, 2025 increased 26 points primarily due to significant adverse development in the second quarter of 2025 and a higher current accident year attritional loss ratio. Adverse development was driven by $74.6 million of increases in prior accident years loss reserves within our general liability product lines due to greater severity than originally expected across older accident years and increases to more recent accident years to incorporate our loss experience on the older accident years. We also increased our current accident year loss ratios on these general liability product lines based on the loss experience on these older accident years. The increases in losses on our general liability product lines were due in part to the previously discussed reserve study conducted in the second quarter of 2025. The increases to prior accident years loss reserves within the general liability product lines were partially offset by favorable development within certain sub-classes of our professional liability product lines.
34
Table of Contents
Year-to-Date
| Six Months Ended June 30, 2025 | |||||||||||||||||||||||||||||||||||
| (dollars in thousands) | U.S. Wholesale and Specialty | Programs and Solutions | International | Global Reinsurance | Other | Markel Insurance | |||||||||||||||||||||||||||||
Underwriting | $ | 1,570,989 | $ | 1,787,129 | $ | 1,347,792 | $ | 898,603 | $ | (2,284) | $ | 5,602,229 | |||||||||||||||||||||||
Fronting | — | 1,671,794 | — | — | — | 1,671,794 | |||||||||||||||||||||||||||||
| Gross premium volume | $ | 1,570,989 | $ | 3,458,923 | $ | 1,347,792 | $ | 898,603 | $ | (2,284) | $ | 7,274,023 | |||||||||||||||||||||||
| Net written premiums | $ | 1,278,942 | $ | 1,164,369 | $ | 1,161,242 | $ | 801,082 | $ | (1,704) | $ | 4,403,931 | |||||||||||||||||||||||
| Earned premiums | $ | 1,322,531 | $ | 1,144,103 | $ | 1,044,483 | $ | 559,652 | $ | 9,392 | $ | 4,080,161 | |||||||||||||||||||||||
| Losses and loss adjustment expenses: | |||||||||||||||||||||||||||||||||||
| Current accident year - attritional | (906,132) | (712,921) | (550,335) | (416,710) | (45,226) | (2,631,324) | |||||||||||||||||||||||||||||
| Current accident year - catastrophe | (18,227) | (16,200) | (25,000) | (1,450) | — | (60,877) | |||||||||||||||||||||||||||||
| Prior accident years | 43,042 | 73,981 | 139,780 | (31,860) | 2,828 | 227,771 | |||||||||||||||||||||||||||||
Underwriting, acquisition and insurance expenses | (450,260) | (423,205) | (432,569) | (160,299) | (6,036) | (1,472,369) | |||||||||||||||||||||||||||||
| Underwriting profit (loss) | $ | (9,046) | $ | 65,758 | $ | 176,359 | $ | (50,667) | $ | (39,042) | $ | 143,362 | |||||||||||||||||||||||
| Services and other revenues | — | 9,234 | 1,926 | — | (263) | 10,897 | |||||||||||||||||||||||||||||
| Services and other expenses | — | (4,805) | (5,343) | — | (7,492) | (17,640) | |||||||||||||||||||||||||||||
| Operating income (loss) | $ | (9,046) | $ | 70,187 | $ | 172,942 | $ | (50,667) | $ | (46,797) | $ | 136,619 | |||||||||||||||||||||||
| Current accident year loss ratio | 69.9 | % | 63.7 | % | 55.1 | % | 74.7 | % | 66.0 | % | |||||||||||||||||||||||||
| Prior accident years loss ratio | (3.3) | % | (6.5) | % | (13.4) | % | 5.7 | % | (5.6) | % | |||||||||||||||||||||||||
| Loss ratio | 66.6 | % | 57.3 | % | 41.7 | % | 80.4 | % | 60.4 | % | |||||||||||||||||||||||||
| Expense ratio | 34.0 | % | 37.0 | % | 41.4 | % | 28.6 | % | 36.1 | % | |||||||||||||||||||||||||
| Combined ratio | 100.7 | % | 94.3 | % | 83.1 | % | 109.1 | % | 96.5 | % | |||||||||||||||||||||||||
| Six Months Ended June 30, 2024 | |||||||||||||||||||||||||||||||||||
| (dollars in thousands) | U.S. Wholesale and Specialty | Programs and Solutions | International | Global Reinsurance | Other | Markel Insurance | |||||||||||||||||||||||||||||
Underwriting | $ | 1,617,189 | $ | 1,642,473 | $ | 1,294,927 | $ | 998,352 | $ | (1,893) | $ | 5,551,048 | |||||||||||||||||||||||
Fronting | — | 1,120,724 | — | — | — | 1,120,724 | |||||||||||||||||||||||||||||
| Gross premium volume | $ | 1,617,189 | $ | 2,763,197 | $ | 1,294,927 | $ | 998,352 | $ | (1,893) | $ | 6,671,772 | |||||||||||||||||||||||
| Net written premiums | $ | 1,290,760 | $ | 1,067,540 | $ | 1,105,752 | $ | 901,622 | $ | (1,045) | $ | 4,364,629 | |||||||||||||||||||||||
| Earned premiums | $ | 1,432,966 | $ | 1,077,843 | $ | 984,867 | $ | 541,006 | $ | 13,963 | $ | 4,050,645 | |||||||||||||||||||||||
| Losses and loss adjustment expenses: | |||||||||||||||||||||||||||||||||||
| Current accident year - attritional | (988,045) | (674,576) | (550,160) | (369,490) | (67,316) | (2,649,587) | |||||||||||||||||||||||||||||
| Current accident year - catastrophe | — | — | — | — | — | — | |||||||||||||||||||||||||||||
| Prior accident years | 54,540 | 33,772 | 187,466 | (6,007) | (45,669) | 224,102 | |||||||||||||||||||||||||||||
Underwriting, acquisition and insurance expenses | (476,691) | (376,529) | (391,311) | (153,698) | (5,837) | (1,404,066) | |||||||||||||||||||||||||||||
| Underwriting profit (loss) | $ | 22,770 | $ | 60,510 | $ | 230,862 | $ | 11,811 | $ | (104,859) | $ | 221,094 | |||||||||||||||||||||||
| Services and other revenues | — | 7,367 | 3,682 | — | (357) | 10,692 | |||||||||||||||||||||||||||||
| Services and other expenses | — | (2,098) | (4,904) | — | (6,160) | (13,162) | |||||||||||||||||||||||||||||
| Operating income (loss) | $ | 22,770 | $ | 65,779 | $ | 229,640 | $ | 11,811 | $ | (111,376) | $ | 218,624 | |||||||||||||||||||||||
| Current accident year loss ratio | 69.0 | % | 62.6 | % | 55.9 | % | 68.3 | % | 65.4 | % | |||||||||||||||||||||||||
| Prior accident years loss ratio | (3.8) | % | (3.1) | % | (19.0) | % | 1.1 | % | (5.5) | % | |||||||||||||||||||||||||
| Loss ratio | 65.1 | % | 59.5 | % | 36.8 | % | 69.4 | % | 59.9 | % | |||||||||||||||||||||||||
| Expense ratio | 33.3 | % | 34.9 | % | 39.7 | % | 28.4 | % | 34.7 | % | |||||||||||||||||||||||||
| Combined ratio | 98.4 | % | 94.4 | % | 76.6 | % | 97.8 | % | 94.5 | % | |||||||||||||||||||||||||
35
Table of Contents
U.S. Wholesale and Specialty
The 3% decrease in gross premium volume and 8% decrease in earned premiums within the U.S. Wholesale and Specialty division for the six months ended June 30, 2025 was primarily due to the impact of exiting our U.S. risk-managed directors and officers product line from this platform. The U.S. Wholesale and Specialty division combined ratio for the six months ended June 30, 2025 increased two points primarily due to losses attributed to the California Wildfires in 2025. Favorable development in the first half of 2025 was net of $90.3 million, or 7 points on the U.S. Wholesale and Specialty combined ratio, of adverse development on our run-off U.S. risk-managed directors and officers product line.
Programs and Solutions
The 9% increase in gross premium volume and 6% increase in earned premiums within the Programs and Solutions division for the six months ended June 30, 2025 was driven by more favorable rates and new business within our personal lines and programs product lines, partially offset by the impact of exiting our European risk-managed directors and officers product line. The significant growth in fronting gross premium volume was driven by expansion of our property catastrophe programs with the Nephila Reinsurers.
The Programs and Solutions division's combined ratio for the six months ended June 30, 2025 was consistent with the first half of 2024 at 94% as the impact of more favorable development on prior accident years loss reserves was offset by a higher expense ratio and losses attributed to the California Wildfires in 2025. Favorable development in the first half of 2025 was net of $37.6 million, or three points on the Programs and Solutions combined ratio, of adverse development on our run-off European risk-managed directors and officers product line.
International
The 4% increase in gross premium volume within the International division for the six months ended June 30, 2025 was driven by modest increases on our general liability, professional liability and equine product lines. The 6% increase in earned premiums was driven by higher premium volume in recent periods across the portfolio. The International division's combined ratio for the six months ended June 30, 2025 increased seven points primarily due to less favorable development on prior accident years loss reserves and losses attributed to the California Wildfires in 2025, partially offset by a lower current accident year attritional loss ratio.
Global Reinsurance
Gross premium volume within the Global Reinsurance division for the quarter ended June 30, 2025 decreased by 10% due to unfavorable timing differences, as previously discussed. The Global Reinsurance division's combined ratio for the six months ended June 30, 2025 increased 11 points primarily due to the same factors as discussed on a quarter-to-date basis, however, these drivers had a less significant impact over the six month period.
Other Insurance Operations
The following tables present the components of operating revenues and operating income attributable to our other insurance businesses, which are not included in a reportable segment. We do not allocate amortization of acquired intangible assets to our operating segments, including our other insurance operations.
| Quarter Ended June 30, | |||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| (dollars in thousands) | Operating revenues | Operating income | Operating revenues | Operating income | |||||||||||||||||||
| State National | $ | 122,337 | $ | 49,134 | $ | 115,030 | $ | 41,210 | |||||||||||||||
Nephila | 29,131 | 6,685 | 21,835 | 3,475 | |||||||||||||||||||
Other (1) | 10,384 | 12,256 | 926 | 8,344 | |||||||||||||||||||
| Other insurance operations | $ | 161,852 | $ | 68,075 | $ | 137,791 | $ | 53,029 | |||||||||||||||
(1) Other is primarily comprised of the results attributable to our minority investment in Velocity Holdco, LLC (Velocity) and to Markel CATCo Re (MCRe). Results attributable to MCRe for both periods were entirely attributable to noncontrolling interest holders in MCRe.
36
Table of Contents
Six Months Ended June 30, | |||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| (dollars in thousands) | Operating revenues | Operating income | Operating revenues | Operating income (loss) | |||||||||||||||||||
| State National | $ | 232,151 | $ | 84,165 | $ | 229,909 | $ | 72,518 | |||||||||||||||
Nephila | 54,626 | 8,960 | 41,074 | (2,130) | |||||||||||||||||||
Other (1) | 42,045 | 43,704 | 1,666 | 23,738 | |||||||||||||||||||
| Other insurance operations | $ | 328,822 | $ | 136,829 | $ | 272,649 | $ | 94,126 | |||||||||||||||
(1) Other is primarily comprised of the results attributable to our minority investment in Velocity and to MCRe. Results attributable to MCRe for both periods were entirely attributable to noncontrolling interest holders in MCRe.
State National
The increase in operating revenues from our State National business for the quarter ended June 30, 2025 was primarily due to higher earned premiums within our lender services underwriting operations. The increase in operating income from our State National business for the quarter and six months ended June 30, 2025 was primarily attributable to an improved combined ratio within our lender services underwriting operations.
Nephila
The increase in operating revenues and operating income from our Nephila fund management operations for the quarter and six months ended June 30, 2025 was primarily attributable to the impact of a higher effective management fee rate.
Other
Operating revenues and operating income for the quarter and six months ended June 30, 2025 were primarily attributable to income related to our minority investment in Velocity, following the sale of its managing general agent operations in February 2025 and of its insurance carrier in May 2025.
Consolidated Underwriting Reconciliation
The following tables reconcile our Markel Insurance segment underwriting results to our consolidated underwriting operations.
Quarter Ended June 30, | |||||||||||||||||||||||||||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||||||||||||||||||||||||||
| (dollars in thousands) | Markel Insurance | State National | Eliminations | Consolidated | Markel Insurance | State National | Eliminations | Consolidated | |||||||||||||||||||||||||||||||||||||||
Underwriting | $ | 2,808,823 | $ | 77,845 | $ | — | $ | 2,886,668 | $ | 2,852,600 | $ | 68,787 | $ | — | $ | 2,921,387 | |||||||||||||||||||||||||||||||
Fronting | 1,293,649 | 1,006,942 | (42,768) | 2,257,823 | 811,895 | 997,470 | (18,622) | 1,790,743 | |||||||||||||||||||||||||||||||||||||||
| Gross premium volume | $ | 4,102,472 | $ | 1,084,787 | $ | (42,768) | $ | 5,144,491 | $ | 3,664,495 | $ | 1,066,257 | $ | (18,622) | $ | 4,712,130 | |||||||||||||||||||||||||||||||
| Earned premiums | $ | 2,063,622 | $ | 78,069 | $ | — | $ | 2,141,691 | $ | 2,004,166 | $ | 72,933 | $ | — | $ | 2,077,099 | |||||||||||||||||||||||||||||||
Losses and loss adjustment expenses | (1,251,680) | (36,354) | — | (1,288,034) | (1,189,405) | (43,170) | — | (1,232,575) | |||||||||||||||||||||||||||||||||||||||
Underwriting, acquisition and insurance expenses | (748,742) | (25,469) | — | (774,211) | (690,627) | (19,668) | — | (710,295) | |||||||||||||||||||||||||||||||||||||||
| Underwriting profit | $ | 63,200 | $ | 16,246 | $ | — | $ | 79,446 | $ | 124,134 | $ | 10,095 | $ | — | $ | 134,229 | |||||||||||||||||||||||||||||||
| Combined Ratio | 96.9 | % | 79.2 | % | 96.3 | % | 93.8 | % | 86.2 | % | 93.5 | % | |||||||||||||||||||||||||||||||||||
37
Table of Contents
Six Months Ended June 30, | |||||||||||||||||||||||||||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||||||||||||||||||||||||||
| (dollars in thousands) | Markel Insurance | State National | Eliminations | Consolidated | Markel Insurance | State National | Eliminations | Consolidated | |||||||||||||||||||||||||||||||||||||||
Underwriting | $ | 5,602,229 | $ | 149,455 | $ | — | $ | 5,751,684 | $ | 5,551,048 | $ | 146,505 | $ | — | $ | 5,697,553 | |||||||||||||||||||||||||||||||
Fronting | 1,671,794 | 2,035,608 | (96,365) | 3,611,037 | 1,120,724 | 1,874,553 | (40,301) | 2,954,976 | |||||||||||||||||||||||||||||||||||||||
| Gross premium volume | $ | 7,274,023 | $ | 2,185,063 | $ | (96,365) | $ | 9,362,721 | $ | 6,671,772 | $ | 2,021,058 | $ | (40,301) | $ | 8,652,529 | |||||||||||||||||||||||||||||||
| Earned premiums | $ | 4,080,161 | $ | 150,904 | $ | — | $ | 4,231,065 | $ | 4,050,645 | $ | 154,081 | $ | — | $ | 4,204,726 | |||||||||||||||||||||||||||||||
Losses and loss adjustment expenses | (2,464,430) | (78,269) | — | (2,542,699) | (2,425,485) | (94,837) | — | (2,520,322) | |||||||||||||||||||||||||||||||||||||||
Underwriting, acquisition and insurance expenses | (1,472,369) | (49,280) | — | (1,521,649) | (1,404,066) | (44,981) | — | (1,449,047) | |||||||||||||||||||||||||||||||||||||||
| Underwriting profit | $ | 143,362 | $ | 23,355 | $ | — | $ | 166,717 | $ | 221,094 | $ | 14,263 | $ | — | $ | 235,357 | |||||||||||||||||||||||||||||||
| Combined Ratio | 96.5 | % | 84.5 | % | 96.1 | % | 94.5 | % | 90.7 | % | 94.4 | % | |||||||||||||||||||||||||||||||||||
Investing Results
We measure our investment performance by analyzing net investment income, which reflects the recurring interest and dividend earnings on our investment portfolio. We also analyze net investment gains, which include unrealized gains and losses on our equity portfolio. Based on the potential for volatility in the financial markets, we understand that the level of gains or losses may vary from one period to the next, and therefore believe that our investment performance is best analyzed over longer periods of time. As of June 30, 2025, the fair value of our equity portfolio included cumulative unrealized gains of $8.3 billion.
The following table summarizes our consolidated investment performance, which consists predominantly of the results of our Investing segment. Net investment gains or losses in any given period are typically attributable to changes in the fair value of our equity portfolio due to market value movements. The change in net unrealized losses on available-for-sale investments in any given period is typically attributable to changes in the fair value of our fixed maturity portfolio due to changes in interest rates during the period. In 2025, the change in net unrealized losses on available-for-sale investments was also driven by foreign exchange gains on available-for-sale securities denominated in a foreign currency attributed to changes in exchange rates during 2025. As of June 30, 2025, 96% of our fixed maturity portfolio was rated "AA" or better.
| Quarter Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (dollars in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Net investment income | $ | 230,009 | $ | 223,061 | $ | 467,104 | $ | 441,330 | |||||||||||||||
Yield on fixed maturity securities (1) | 3.5 | % | 3.1 | % | 3.5 | % | 3.2 | % | |||||||||||||||
Yield on short-term investments (1) | 3.9 | % | 4.7 | % | 3.8 | % | 4.8 | % | |||||||||||||||
Yield on cash and cash equivalents and restricted cash and cash equivalents (1) | 3.3 | % | 4.0 | % | 3.4 | % | 3.7 | % | |||||||||||||||
| Net realized investment losses | $ | (16,596) | $ | (14,007) | $ | (18,397) | $ | (18,495) | |||||||||||||||
| Change in fair value of equity securities | 596,819 | (116,010) | 449,549 | 790,759 | |||||||||||||||||||
| Net investment gains (losses) | $ | 580,223 | $ | (130,017) | $ | 431,152 | $ | 772,264 | |||||||||||||||
Return on equity securities (2) | 5.4 | % | (0.8) | % | 4.5 | % | 8.9 | % | |||||||||||||||
Other (3) | $ | 14,064 | $ | 9,357 | $ | 9,454 | $ | 30,203 | |||||||||||||||
| Change in net unrealized losses on available-for-sale investments | $ | 258,329 | $ | (36,598) | $ | 535,556 | $ | (192,367) | |||||||||||||||
(1) Yields reflect the applicable annualized interest income as a percentage of the applicable monthly average invested assets at amortized cost.
(2) Return on equity securities is calculated by dividing dividends and the change in fair value of equity securities by the monthly average equity securities at fair value and considers the timing of net purchases and sales.
(3) Other income or losses within our investing operations primarily relate to equity method investments in our investing segment, which are managed separately from the rest of our investment portfolio.
38
Table of Contents
The increase in net investment income for the quarter and six months ended June 30, 2025 was driven by higher interest income on fixed maturity securities due to a higher yield and higher average holdings of fixed maturity securities in 2025 compared to 2024. These increases were partially offset by lower interest income on our short-term investments and cash equivalents due in part to lower short-term interest rates, as well as lower average short-term investment holdings as we used proceeds from our May 2024 senior debt offering, which had been held in short-term investments, to redeem our preferred shares in the second quarter of 2025. We continue to allocate cash to money market funds and fixed maturity securities to take advantage of high interest rates. See note 4(d) of the notes to consolidated financial statements for details regarding the components of net investment income.
Markel Ventures Results
We measure the operating performance of our Markel Ventures segment by its operating income, as well as earnings before interest, income taxes, depreciation and amortization (EBITDA). We consolidate the results of our Markel Ventures subsidiaries on a one-month lag, with the exception of significant transactions or events that occur during the intervening period. The following table summarizes the results from our Markel Ventures segment.
| Quarter Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||||||||||||||
| (dollars in thousands) | 2025 | 2024 | % Change | 2025 | 2024 | % Change | |||||||||||||||||||||||||||||
| Operating revenues | $ | 1,548,286 | $ | 1,453,781 | 7 | % | $ | 2,677,658 | $ | 2,594,387 | 3 | % | |||||||||||||||||||||||
| Segment operating income | $ | 207,728 | $ | 177,498 | 17 | % | $ | 310,238 | $ | 281,413 | 10 | % | |||||||||||||||||||||||
| EBITDA | $ | 239,637 | $ | 207,139 | 16 | % | $ | 374,382 | $ | 340,784 | 10 | % | |||||||||||||||||||||||
For the quarter and six months ended June 30, 2025, the increases in operating revenues reflected the contribution of revenues from acquisitions totaling $36.8 million and $64.8 million, respectively, as well as increased demand at our construction services businesses. We acquired Valor and EPI in June 2024 and September 2024, respectively. The increase in operating revenues for the six months ended June 30, 2025 also reflected higher revenues from our equipment manufacturing businesses due to increased demand. For both the quarter and six months ended June 30, 2025, these increases in operating revenues were partially offset by lower demand at our transportation-related businesses.
For the quarter and six months ended June 30, 2025, the increases in segment operating income and EBITDA were primarily due to the impact of higher revenues and improved margins at our constructions services businesses, as well as contributions from Valor and EPI. These increases were offset by lower segment operating income and EBITDA at our transportation-related businesses for the quarter and six months ended June 30, 2025, primarily due to the impact of lower revenues.
Markel Ventures segment EBITDA is a non-GAAP financial measure. We use Markel Ventures segment EBITDA as an operating performance measure in conjunction with our segment performance metric, segment operating income, to monitor and evaluate the performance of our Markel Ventures segment. Because EBITDA excludes interest, income taxes, depreciation and amortization, it provides an indicator of economic performance that is useful to both management and investors in evaluating our Markel Ventures businesses as it is not affected by levels of debt, interest rates, effective tax rates or levels of depreciation or amortization resulting from purchase accounting. The following table reconciles Markel Ventures segment operating income to EBITDA.
| Quarter Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (dollars in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Markel Ventures segment operating income | $ | 207,728 | $ | 177,498 | $ | 310,238 | $ | 281,413 | |||||||||||||||
| Depreciation expense | 31,909 | 29,641 | 64,144 | 59,371 | |||||||||||||||||||
| Markel Ventures segment EBITDA | $ | 239,637 | $ | 207,139 | $ | 374,382 | $ | 340,784 | |||||||||||||||
39
Table of Contents
Other
The following table presents the components of consolidated net income that are not allocated to our operating segments.
| Quarter Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (dollars in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Amortization of acquired intangible assets | $ | 51,213 | $ | 44,237 | $ | 98,155 | $ | 88,522 | |||||||||||||||
| Interest expense | $ | 53,076 | $ | 52,597 | $ | 105,216 | $ | 98,145 | |||||||||||||||
| Net foreign exchange (gains) losses | $ | 191,909 | $ | (8,711) | $ | 264,542 | $ | (60,211) | |||||||||||||||
| Income tax expense | $ | 185,170 | $ | 76,244 | $ | 213,574 | $ | 368,800 | |||||||||||||||
| Effective tax rate | 21 | % | 22 | % | |||||||||||||||||||
Interest Expense
The increase in interest expense for the quarter and six months ended June 30, 2025 compared to the same period of 2024 was primarily attributable to the issuance of our $600 million 6.0% unsecured senior notes in May 2024.
Net Foreign Exchange Gains and Losses
Net foreign exchange gains and losses are primarily due to the remeasurement of our foreign currency denominated insurance loss reserves to the U.S. Dollar. The predominant foreign currencies within our insurance operations are the Euro and the British Pound. The U.S. Dollar weakened against the Euro and the British Pound during the first half of 2025, while it strengthened against these currencies during the first half of 2024. Our exposure to foreign currency exchange rates is largely hedged through our available-for-sale investment portfolio, where we hold securities that generally match the currencies of our loss reserves. We also purchase foreign currency forward contracts to further manage unmatched foreign currency exposures. Pre-tax net foreign exchange gains and losses attributed to changes in exchange rates on available-for-sale securities supporting our insurance reserves, which are included in the changes in net unrealized losses on available-for-sale investments in other comprehensive income (loss), were gains of $158.4 million and $222.7 million for the quarter and six months ended June 30, 2025, respectively, compared to losses of $3.1 million and $45.5 million for the same periods of 2024.
Income Taxes
On July 4, 2025, the U.S. enacted legislation known as the One Big Beautiful Bill Act of 2025 (the 2025 Act) which makes permanent many of the tax provisions enacted in 2017 as part of the Tax Cuts and Jobs Act that were set to expire at the end of 2025. In addition, the 2025 Act makes changes to certain U.S. corporate tax provisions, most of which are not effective until 2026. We do not expect the Act to have a material impact on our results of operations, financial condition or cash flows, however, we will continue to evaluate the impact of the 2025 Act.
Other Comprehensive Income (Loss) to Shareholders
The following table summarizes the components of other comprehensive income (loss) to shareholders.
| Quarter Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (dollars in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Change in net unrealized losses on available-for-sale investments, net of taxes | $ | 202,512 | $ | (28,870) | $ | 420,889 | $ | (151,572) | |||||||||||||||
| Change in discount rate for life and annuity benefits, net of taxes | (1,664) | 5,973 | 5,714 | 12,391 | |||||||||||||||||||
| Other, net of taxes | 9,556 | (436) | 9,730 | (891) | |||||||||||||||||||
| Other comprehensive income attributable to noncontrolling interest | (41) | (12) | (14) | (72) | |||||||||||||||||||
| Other comprehensive income (loss) to shareholders | $ | 210,363 | $ | (23,345) | $ | 436,319 | $ | (140,144) | |||||||||||||||
40
Table of Contents
Financial Condition
Liquidity and Capital Resources
We seek to maintain prudent levels of liquidity and financial leverage for the benefit and protection of our policyholders, creditors and shareholders. Our consolidated debt to capital ratio was 20% at both June 30, 2025 and December 31, 2024, which is within the range of our target capital structure.
In June 2025, we redeemed in full our 600,000 6.00% Fixed-Rate Reset Non-Cumulative Series A preferred shares for $1,000 per share, for an aggregate value of $600.0 million. As of June 30, 2025, we had no preferred shares issued and outstanding.
Investments, cash and cash equivalents and restricted cash and cash equivalents (invested assets) were $35.3 billion and $34.2 billion at June 30, 2025 and December 31, 2024, respectively. The following table presents the composition of our invested assets.
| June 30, 2025 | December 31, 2024 | ||||||||||
| Fixed maturity securities | 47 | % | 46 | % | |||||||
| Equity securities | 35 | % | 34 | % | |||||||
| Short-term investments, cash and cash equivalents and restricted cash and cash equivalents | 18 | % | 20 | % | |||||||
| Total | 100 | % | 100 | % | |||||||
Our holding company had $3.6 billion and $4.3 billion of invested assets at June 30, 2025 and December 31, 2024, respectively. The decrease was attributable to cash used to redeem our preferred stock and repurchase shares of our common stock in 2025. The following table presents the composition of our holding company's invested assets.
| June 30, 2025 | December 31, 2024 | ||||||||||
| Fixed maturity securities | 3 | % | 3 | % | |||||||
| Equity securities | 57 | % | 48 | % | |||||||
| Short-term investments, cash and cash equivalents and restricted cash and cash equivalents | 40 | % | 49 | % | |||||||
| Total | 100 | % | 100 | % | |||||||
We have a share repurchase program, authorized by our Board of Directors, that provides for the repurchase of up to $2 billion of common stock. As of June 30, 2025, $1.6 billion remained available for repurchases under the program. This share repurchase program has no expiration date but may be terminated by the Board of Directors at any time.
We may from time to time seek to prepay, retire or repurchase our outstanding senior notes, through open market purchases, privately negotiated transactions or otherwise. Those prepayments, retirements or repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors.
We have access to various capital sources, including dividends from our subsidiaries, holding company invested assets, undrawn capacity under our revolving credit facility and access to the debt and equity capital markets. We believe we have, or have access to, adequate liquidity to meet our capital and operating needs, including that which may be required to support the operating needs of our subsidiaries. However, the availability of these sources of capital and the availability and terms of future financings will depend on a variety of factors.
Cash Flows
Net cash provided by operating activities was $880.6 million for the six months ended June 30, 2025 compared to $1.2 billion for the same period of 2024. The decrease in net cash flows from operating activities for the six months ended June 30, 2025 compared to the same period in 2024 was due to higher gross claims payments and higher personnel costs in our insurance operations.
41
Table of Contents
Net cash provided by investing activities was $83.4 million for the six months ended June 30, 2025 compared to net cash used by investing activities of $1.6 billion for the same period of 2024. During the six months ended June 30, 2025, net cash provided by investing activities included net sales of short-term investments of $729.0 million and net purchases of fixed maturity securities and equity securities of $485.6 million and $96.5 million, respectively. The net sales of short-term investments in 2025 were largely driven by the conversion of short-term investments to cash in order to redeem our preferred stock. During the six months ended June 30, 2024, net cash used by investing activities included net purchases of fixed maturity securities, equity securities and short-term investments of $785.1 million, $223.3 million and $161.3 million, respectively. Net cash used by investing activities in 2024 also included $154.4 million of net cash used for the acquisition of Valor. Cash flows from investing activities are affected by various factors such as anticipated payment of claims, financing activity, acquisition opportunities and individual buy and sell decisions made in the normal course of our investment portfolio management.
For the six months ended June 30, 2025, net cash used by financing activities was $927.7 million, which included $600.0 million of cash used to redeem our preferred stock and $269.6 million of cash used to repurchase shares of our common stock. For the six months ended June 30, 2024, net cash provided by financing activities was $255.2 million, which included net proceeds of $592.6 million from the issuance of senior notes in May 2024, and was net of $260.2 million of cash used to repurchase shares of our common stock. Additionally, financing activities during the six months ended June 30, 2025 and 2024 reflected borrowings and repayments of debt at certain of our Markel Ventures businesses, primarily on revolving lines of credit.
Critical Accounting Estimates
Critical accounting estimates are those estimates that both are important to the portrayal of our financial condition and results of operations and require us to exercise significant judgment. The preparation of financial statements in accordance with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of material contingent assets and liabilities. These estimates, by necessity, are based on assumptions about numerous factors.
Our critical accounting estimates consist of estimates and assumptions used in determining the reserves for unpaid losses and loss adjustment expenses as well as estimates and assumptions used in the valuation of goodwill and intangible assets. We review the adequacy of reserves for unpaid losses and loss adjustment expenses quarterly. Estimates and assumptions for goodwill and intangible assets are reviewed in conjunction with acquisitions and impairment assessments. Goodwill and indefinite-lived intangible assets are reassessed for impairment at least annually. All intangible assets, including goodwill, are also reviewed for impairment when events or circumstances indicate that their carrying value may not be recoverable. Actual results may differ materially from the estimates and assumptions used in preparing the consolidated financial statements.
Readers are urged to review our 2024 Annual Report on Form 10-K for a more complete description of our critical accounting estimates.
Safe Harbor and Cautionary Statement
This report contains statements concerning or incorporating our expectations, assumptions, plans, objectives, future financial or operating performance and other statements that are not historical facts. These statements are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may use words such as "anticipate," "believe," "estimate," "expect," "intend," "predict," "project" and similar expressions as they relate to us or our management.
There are risks and uncertainties that may cause actual results to differ materially from predicted results in forward-looking statements. Factors that may cause actual results to differ are often presented with the forward-looking statements themselves. Additional factors that could cause actual results to differ from those predicted are set forth under Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis of Financial Condition and Results of Operations and Item 7A Quantitative and Qualitative Disclosures About Market Risk in our 2024 Annual Report on Form 10-K or under "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Quantitative and Qualitative Disclosures About Market Risk" and "Risk Factors" in this report, or are included in the items listed below:
•the effect of cyclical trends or changes in market conditions on our Insurance, Investments and Markel Ventures operations, including demand and pricing in the markets in which we operate;
•actions by competitors, including the use of technology and innovation to simplify the customer experience, increase efficiencies, redesign products, alter models and effect other potentially disruptive changes, and the effect of competition on market trends and pricing;
42
Table of Contents
•our efforts to develop new products, expand in targeted markets or improve business processes and workflows may not be successful, may cost more or take longer than expected and may increase or create new risks (e.g., insufficient demand, change to risk exposures, distribution channel conflicts, execution risk, regulatory risk, increased expenditures);
•the frequency and severity of man-made, health-related and natural catastrophes may exceed expectations, are unpredictable and, in the case of some natural catastrophes, may be exacerbated by changing conditions in the climate, oceans and atmosphere, resulting in increased frequency and/or severity of extreme weather-related events;
•we offer insurance and reinsurance coverage against terrorist acts in connection with some of our programs, and in other instances we are legally required to offer terrorism insurance; in both circumstances, we actively manage our exposure, but if there is a covered terrorist attack, we could sustain material losses;
•emerging claim and coverage issues, changing industry practices and evolving legal, judicial, social and other claims and coverage trends or conditions, can increase the scope of coverage, the frequency and severity of claims and the period over which claims may be reported; these factors, as well as uncertainties in the loss estimation process, can adversely impact the adequacy of our loss reserves and our allowance for reinsurance recoverables;
•reinsurance reserves are subject to greater uncertainty than insurance reserves, primarily because of reliance upon the original underwriting decisions made by ceding companies and the longer lapse of time from the occurrence of loss events to their reporting to the reinsurer for ultimate resolution;
•inaccuracies (whether due to data error, human error or otherwise) in the various modeling techniques and data analytics (e.g., scenarios, predictive and stochastic modeling, and forecasting) we use to analyze and estimate exposures, loss trends and other risks associated with our insurance businesses could cause us to misprice our products or fail to appropriately estimate the risks to which we are exposed;
•changes in the assumptions and estimates used in establishing reserves for our life and annuity reinsurance book (which is in runoff), for example, changes in assumptions and estimates of mortality, longevity, morbidity and interest rates, could result in material changes in our estimated loss reserves for that business;
•adverse developments in insurance coverage litigation or other legal or administrative proceedings could result in material increases in our estimates of loss reserves;
•initial estimates for catastrophe losses and other significant, infrequent events are often based on limited information, are dependent on broad assumptions about the nature and extent of losses, coverage, liability and reinsurance, and those losses may ultimately differ materially from our expectations;
•changes in the availability, costs, quality and providers of reinsurance coverage, which may impact our ability to write, or continue to write, certain lines of business or to mitigate the volatility of losses on our results of operations and financial condition;
•the ability or willingness of reinsurers to pay balances due may be adversely affected by industry and economic conditions, deterioration in reinsurer credit quality and coverage disputes, and collateral we hold, if any, may not be sufficient to cover a reinsurer's obligation to us;
•after the commutation of ceded reinsurance contracts, any subsequent adverse development in the re-assumed loss reserves will result in a charge to earnings;
•regulatory actions affecting our insurance operations can impede our ability to charge adequate rates and efficiently allocate capital;
•general economic and market conditions and industry specific conditions, including: extended economic recessions or expansions; prolonged periods of slow economic growth; inflation or deflation; fluctuations in foreign currency exchange rates, commodity and energy prices and interest rates; volatility in the credit and capital markets; the imposition of duties, tariffs and other changes in international trade regulation and other factors;
•economic conditions, actual or potential defaults in corporate bonds, municipal bonds, mortgage-backed securities or sovereign debt obligations, volatility in interest and foreign currency exchange rates, changes in U.S. government debt ratings and changes in market value of concentrated investments can have a significant impact on the fair value of our fixed maturity securities and equity securities, as well as the carrying value of our other assets and liabilities, and this impact may be heightened by market volatility and our ability to mitigate our sensitivity to these changing conditions;
•economic conditions may adversely affect our access to capital and credit markets;
•the effects of government intervention, including material changes in the monetary policies of central banks, to address financial downturns, inflation and other economic and currency concerns;
43
Table of Contents
•the impacts that political and civil unrest and regional conflicts may have on our businesses and the markets they serve or that any disruptions in regional or worldwide economic conditions generally arising from these situations may have on our businesses, industries or investments;
•the impacts of liability, transition and physical risks associated with climate change;
•the significant volatility, uncertainty and disruption caused by health epidemics and pandemics, as well as governmental, legislative, judicial or regulatory actions or developments in response thereto;
•changes in U.S. tax laws, regulations or interpretations, or in the tax laws, regulations or interpretations of other jurisdictions in which we operate, and adjustments we may make in our operations or tax strategies in response to those changes;
•a failure or security breach of, or cyberattack on, enterprise information technology systems that we, or third parties who perform certain functions for us, use, or a failure to comply with data protection or privacy regulations or regulations related to the use of artificial intelligence or machine learning technology;
•third-party providers may perform poorly, breach their obligations to us or expose us to enhanced risks;
•our acquisitions may increase our operational and internal control risks for a period of time;
•we may not realize the contemplated benefits, including cost savings and synergies, of our acquisitions;
•any developments requiring the write-off of a significant portion of our goodwill and intangible assets;
•the failure or inadequacy of any methods we employ to manage our loss exposures;
•the loss of services of any senior executive or other key personnel, or an inability to attract and retain qualified leaders to run any of our businesses could adversely impact one or more of our operations;
•the manner in which our businesses operate through independent local management teams could result in inconsistent management, governance and oversight practices;
•our substantial international operations and investments expose us to increased political, civil, operational and economic risks, including foreign currency exchange rate and credit risk;
•our ability to obtain additional capital for our operations on terms favorable to us;
•the compliance, or failure to comply, with covenants and other requirements under our credit facilities, senior debt and other indebtedness;
•our ability to maintain or raise third-party capital for existing or new investment vehicles and risks related to our management of third-party capital;
•the effectiveness of our procedures for compliance with existing and future guidelines, policies and legal and regulatory standards, rules, laws and regulations;
•the impact of economic and trade sanctions and embargo programs on our businesses, including instances in which the requirements and limitations applicable to the global operations of U.S. companies and their affiliates are more restrictive than, or conflict with, those applicable to non-U.S. companies and their affiliates;
•regulatory changes, or challenges by regulators, regarding the use of certain issuing carrier or fronting arrangements;
•our dependence on a limited number of brokers for a large portion of our insurance revenues;
•adverse changes in our assigned financial strength, debt rating or outlook could adversely impact us, including our ability to attract and retain business, the amount of capital our insurance subsidiaries must hold and the availability and cost of capital;
•changes in the amount of statutory capital our insurance subsidiaries are required to hold, which can vary significantly and is based on many factors, some of which are outside our control;
•losses from litigation and regulatory investigations and actions;
•disruptions resulting from a threatened proxy contest or other actions by activist shareholders;
•considerations and limitations relating to the use of intrinsic value as a performance metric, including the possibility that shareholders, analysts or other market participants may have a different perception of our intrinsic value, which may result in our stock price varying significantly from our intrinsic value calculations; and
44
Table of Contents
•a number of additional factors may adversely affect our Markel Ventures businesses, and the markets they serve, and negatively impact their revenues and profitability, including, among others: adverse weather conditions, plant disease and other contaminants; changes in government support for education, healthcare and infrastructure projects; changes in capital spending levels; changes in the housing, commercial and industrial construction markets; liability for environmental matters; supply chain and shipping issues, including increases in freight costs; volatility in the market prices for their products; and volatility in commodity, wholesale and raw materials prices and interest and foreign currency exchange rates.
Results from our Insurance, Investments and Markel Ventures operations have been and will continue to be potentially materially affected by these factors.
By making forward-looking statements, we do not intend to become obligated to publicly update or revise any such statements whether as a result of new information, future events or other changes. Readers are cautioned not to place undue reliance on any forward-looking statements, which are based on our current knowledge and speak only as at their dates.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Market risk is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument as the result of changes in equity prices, interest rates, foreign currency exchange rates and commodity prices. Our consolidated balance sheets include assets and liabilities with estimated fair values that are subject to market risk. Our primary market risks are equity price risk associated with investments in equity securities, interest rate risk associated with investments in fixed maturity securities and foreign currency exchange rate risk associated with our international operations. During the six months ended June 30, 2025, there were no material changes in our market risk exposures from those described in our 2024 Annual Report on Form 10-K.
Credit Risk
Credit risk, which is not considered a market risk, is the risk that an entity becomes unable or unwilling to fulfill its obligations to us. Our primary credit risks are the credit risk within our fixed maturity portfolio and the credit risk related to our reinsurance recoverables. During the six months ended June 30, 2025, there were no material changes in our credit risk exposures from those described in our 2024 Annual Report on Form 10‑K.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this quarterly report, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (Disclosure Controls), as defined under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act). This evaluation was conducted under the supervision and with the participation of our management, including the Principal Executive Officer (PEO) and the Principal Financial Officer (PFO).
Based upon this evaluation, the PEO and PFO concluded that effective Disclosure Controls were in place to ensure that the information required to be disclosed in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms.
Changes in Internal Control over Financial Reporting
During the second quarter of 2025, we implemented a new actuarial reserving system within Markel Insurance to store, model and review actuarial data. The new system provides our actuarial reserving process with improved performance and additional functionality. Throughout the transition and upon implementation of the new system, we evaluated the impact of the new system on our internal control over financial reporting and added new controls or made updates to controls as necessary. There were no other changes in our internal control over financial reporting during the second quarter of 2025 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
45
Table of Contents
PART II. OTHER INFORMATION
Item 1A. Risk Factors
Throughout the first half of 2025, the U.S. has announced new, as well as changes in, tariffs on a broad range of foreign imports. These tariffs, and any additional duties, tariffs and other trade barriers, imposed or modified by the U.S., and retaliatory or responsive countermeasures by other countries, may adversely affect the price and availability of goods for our businesses and the demand for our products. Additionally, any such measures or countermeasures may increase inflationary pressure on our insured losses and loss adjustment expenses. These impacts may be material, and our efforts to mitigate these impacts may not be successful and, even when they are successful, there may be a time lag before the impacts of these efforts are reflected in our results. See Item 1A Risk Factors in our 2024 Annual Report on Form 10-K for more discussion of these risks, including under:
•"Our results may be affected because actual insured or reinsured losses differ from our loss reserves."
•"Our investment results may be impacted by changes in interest rates, U.S. and international monetary and fiscal policies as well as broader economic conditions."
•"General economic, market or industry conditions could lead to investment losses, adverse effects on our businesses and limit our access to the capital markets."
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table summarizes our common share repurchases for the quarter ended June 30, 2025.
| Issuer Purchases of Equity Securities | |||||||||||||||||||||||
| (a) | (b) | (c) | (d) | ||||||||||||||||||||
| Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1) | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in thousands) | ||||||||||||||||||||
| April 1, 2025 through April 30, 2025 | 24,810 | $ | 1,775.39 | 24,810 | $ | 1,695,108 | |||||||||||||||||
| May 1, 2025 through May 31, 2025 | 15,312 | $ | 1,886.29 | 15,312 | $ | 1,666,225 | |||||||||||||||||
| June 1, 2025 through June 30, 2025 | 9,018 | $ | 1,943.32 | 9,018 | $ | 1,648,700 | |||||||||||||||||
| Total | 49,140 | $ | 1,840.76 | 49,140 | $ | 1,648,700 | |||||||||||||||||
(1) The Board of Directors approved the repurchase of up to $2 billion of our common shares pursuant to a share repurchase program publicly announced in November 2024. Under our share repurchase program, we may repurchase outstanding common shares of our stock from time to time in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 and Rule 10b-18 under the Exchange Act. The share repurchase program has no expiration date but may be terminated by the Board at any time.
Item 5. Other Information
During the Company's quarterly period ended June 30, 2025, no director or officer (as defined in Exchange Act Rule 16a-1(f)) of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" as defined in Regulation S-K Item 408.
46
Table of Contents
Item 6. Exhibits
| Exhibit No. | Document Description | ||||
3.1 | Amended and Restated Articles of Incorporation (incorporated by reference from Exhibit 3.1 in the Registrant's report on Form 8-K filed with the Commission June 4, 2025) | ||||
3.2 | Bylaws, as amended and restated May 26, 2023 (incorporated by reference from Exhibit 3.2 in the Registrant's report on Form 10-Q filed with the Commission for the quarter ended June 30, 2023) | ||||
4.1(a) | Indenture dated as of June 5, 2001, between Markel Corporation and The Chase Manhattan Bank, as Trustee (incorporated by reference from Exhibit 4.1 in the Registrant's report on Form 8-K filed with the Commission June 5, 2001) | ||||
4.1(b) | Form of Third Supplemental Indenture dated as of August 13, 2004, between Markel Corporation and JPMorgan Chase Bank (formerly known as The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.2 in the Registrant's report on Form 8-K filed with the Commission August 11, 2004) | ||||
4.1(c) | Form of Ninth Supplemental Indenture dated as of March 8, 2013, between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.3 in the Registrant's report on Form 8-K filed with the Commission March 7, 2013) | ||||
4.1(d) | Form of Tenth Supplemental Indenture dated as of April 5, 2016, between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.2 in the Registrant's report on Form 8-K filed with the Commission March 31, 2016) | ||||
4.1(e) | Eleventh Supplemental Indenture dated as of November 2, 2017, between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.2 in the Registrant's report on Form 8-K filed with the Commission November 2, 2017) | ||||
4.1(f) | Twelfth Supplemental Indenture dated as of November 2, 2017, between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.3 in the Registrant's report on Form 8-K filed with the Commission November 2, 2017) | ||||
4.1(g) | Thirteenth Supplemental Indenture, dated as of May 20, 2019, between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.2 in the Registrant's report on Form 8-K filed with the Commission May 20, 2019) | ||||
4.1(h) | Fourteenth Supplemental Indenture, dated as of September 17, 2019, between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.2 in the Registrant's report on Form 8-K filed with the Commission September 17, 2019) | ||||
4.1(i) | Fifteenth Supplemental Indenture, dated as of September 17, 2019, between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.3 in the Registrant's report on Form 8-K filed with the Commission September 17, 2019) | ||||
4.1(j) | Sixteenth Supplemental Indenture, dated as of May 7, 2021, between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.2 in the Registrant's report on Form 8-K filed with the Commission May 7, 2021) | ||||
4.1(k) | Seventeenth Supplemental Indenture, dated as of May 16, 2024, between Markel Group Inc. and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.2 in the Registrant's report on Form 8-K filed with the Commission May 16, 2024) | ||||
| The registrant hereby agrees to furnish to the Securities and Exchange Commission, upon request, a copy of all other instruments defining the rights of holders of long-term debt of the registrant and its subsidiaries. | |||||
31.1 | Certification of Principal Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a)* | ||||
31.2 | Certification of Principal Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a)* | ||||
47
Table of Contents
32.1 | Certification furnished Pursuant to 18 U.S.C. Section 1350* | ||||
| 101 | The following consolidated financial statements from Markel Group Inc.'s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, filed on July 30, 2025, formatted in Inline XBRL: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Income and Comprehensive Income, (iii) Consolidated Statements of Changes in Equity, (iv) Condensed Consolidated Statements of Cash Flows and (v) Notes to Consolidated Financial Statements.* | ||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
* Filed with this report
48
Table of Contents
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, this 30th day of July 2025.
| Markel Group Inc. | ||||||||
| By: | /s/ Thomas S. Gayner | |||||||
| Thomas S. Gayner | ||||||||
| Chief Executive Officer | ||||||||
| (Principal Executive Officer) | ||||||||
| By: | /s/ Brian J. Costanzo | |||||||
Brian J. Costanzo | ||||||||
| Chief Financial Officer | ||||||||
| (Principal Financial Officer) | ||||||||
49
Source:
FAQ
How much capital did Celularity (CELU) raise in the July 2025 private placement?
The company raised $2.0 million in gross proceeds from the sale of shares and warrants.
What is the price and structure of the new Celularity units?
Each unit consists of one Class A share plus a warrant, sold at $1.625 per unit.
At what price can the new Celularity warrants be exercised?
The two-year warrants are exercisable immediately at $1.50 per share.
How will Celularity use the proceeds from this financing?
Management states the net proceeds will fund working capital and general corporate purposes.
Will the transaction dilute existing Celularity shareholders?
Yes. The share issuance represents roughly 3-4 % dilution, with further dilution possible if warrants are exercised.
Markel Corporation
NYSE:MKL
MKL Rankings
MKL Latest News
MKL Latest SEC Filings
Jul 16, 2025
[Form 4] Markel Group Inc. Insider Trading Activity
Jul 16, 2025
[Form 4] Markel Group Inc. Insider Trading Activity
MKL Stock Data
25.60B
12.45M
2.04%
80.37%
1.36%
Insurance - Property & Casualty
Fire, Marine & Casualty Insurance
United States
GLEN ALLEN